-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F+pyHKHl+GmLeFDMqF4WqIJnHbD+S4NGV80JgvfJtu5nX3/GAQ3HXPcidTkoc+/D h+SP/w4W25/vnpBfZTez9w== 0001362310-07-000694.txt : 20070508 0001362310-07-000694.hdr.sgml : 20070508 20070508141148 ACCESSION NUMBER: 0001362310-07-000694 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20070331 FILED AS OF DATE: 20070508 DATE AS OF CHANGE: 20070508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RADISYS CORP CENTRAL INDEX KEY: 0000873044 STANDARD INDUSTRIAL CLASSIFICATION: COMPUTER PERIPHERAL EQUIPMENT, NEC [3577] IRS NUMBER: 930945232 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-26844 FILM NUMBER: 07827487 BUSINESS ADDRESS: STREET 1: 5445 NE DAWSON CREEK DR CITY: HILLSBORO STATE: OR ZIP: 97124 BUSINESS PHONE: 5036461800 MAIL ADDRESS: STREET 1: 5445 NE DAWSON CREEK DRIVE CITY: HILLSBORO STATE: OR ZIP: 97124 10-Q 1 c70473e10vq.htm FORM 10-Q e10vq
Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2007
OR
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from           to
Commission file number 0-26844
RADISYS CORPORATION
(Exact name of registrant as specified in its charter)
     
OREGON
(State or other jurisdiction of
Incorporation or Organization)
  93-0945232
(I.R.S. Employer
Identification Number)
5445 N.E. Dawson Creek Drive
Hillsboro, OR 97124

(Address of principal executive offices, including zip code)
(503) 615-1100
(Registrant’s telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o     Accelerated filer þ     Non-accelerated filer o
Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act) Yes o     No þ
Number of shares of common stock outstanding as of May 3, 2007: 21,954,029
 
 

 

 


 

RADISYS CORPORATION
FORM 10-Q
TABLE OF CONTENTS
         
    Page  
PART I. FINANCIAL INFORMATION
 
       
    3  
    3  
    4  
    5  
    6  
    7  
    16  
    26  
    26  
 
       
PART II. OTHER INFORMATION
 
       
    27  
    27  
    28  
 
       
 Exhibit 3.1
 Exhibit 31.1
 Exhibit 31.2
 Exhibit 32.1
 Exhibit 32.2

 

2


Table of Contents

PART I. FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
RADISYS CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts, unaudited)
                 
    For the Three Months  
    Ended March 31,  
    2007     2006  
Revenues
  $ 66,853     $ 65,811  
Cost of sales
    47,612       48,077  
 
           
Gross margin
    19,241       17,734  
Research and development
    10,780       9,124  
Selling, general and administrative
    11,428       8,205  
Intangible assets amortization
    4,258       325  
Restructuring and other charges
    88       59  
 
           
Income (loss) from operations
    (7,313 )     21  
Interest expense
    (432 )     (436 )
Interest income
    1,629       2,236  
Other (expense) income, net
    (56 )     11  
 
           
Income (loss) before income tax provision (benefit)
    (6,172 )     1,832  
Income tax provision (benefit)
    (780 )     406  
 
           
Net income (loss)
  $ (5,392 )   $ 1,426  
 
           
Net income (loss) per share:
               
Basic
  $ (0.25 )   $ 0.07  
 
           
Diluted
  $ (0.25 )   $ 0.07  
 
           
Weighted average shares outstanding:
               
Basic
    21,682       20,699  
 
           
Diluted
    21,682       25,549  
 
           
The accompanying notes are an integral part of these financial statements.

 

3


Table of Contents

RADISYS CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands)
                 
    March 31,     December 31,  
    2007     2006  
    (Unaudited)        
ASSETS
               
Current assets:
               
Cash and cash equivalents
  $ 26,631     $ 23,734  
Short-term investments, net
    89,150       102,250  
Accounts receivable, net
    49,840       42,549  
Other receivables
    5,545       3,782  
Inventories, net
    33,752       35,184  
Assets held for sale
    3,497       3,497  
Other current assets
    4,015       4,609  
Deferred tax assets
    5,779       5,779  
 
           
Total current assets
    218,209       221,384  
Property and equipment, net
    10,767       11,075  
Goodwill
    67,041       67,183  
Intangible assets, net
    38,678       42,935  
Long-term investments, net
    10,000       10,000  
Long-term deferred tax assets
    25,259       24,531  
Other assets
    4,460       4,546  
 
           
Total assets
  $ 374,414     $ 381,654  
 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Current liabilities:
               
Accounts payable
  $ 34,425     $ 39,699  
Accrued wages and bonuses
    5,359       5,995  
Accrued interest payable
    532       222  
Accrued restructuring
    252       329  
Convertible subordinated notes, net
    2,413       2,410  
Other accrued liabilities
    9,815       11,154  
 
           
Total current liabilities
    52,796       59,809  
 
           
Long-term liabilities:
               
Convertible senior notes, net
    97,446       97,412  
Other long-term liabilities
    2,821       978  
 
           
Total long-term liabilities
    100,267       98,390  
 
           
Total liabilities
    153,063       158,199  
 
           
Shareholders’ equity:
               
Preferred stock — $.01 par value, 10,000 shares authorized; none issued or outstanding
           
Common stock — no par value, 100,000 shares authorized; 21,952 and 21,835 shares issued and outstanding at March 31, 2007 and December 31, 2006
    216,425       212,887  
Retained earnings
    875       6,555  
Accumulated other comprehensive income:
               
Cumulative currency translation adjustments
    4,051       4,013  
 
           
Total shareholders’ equity
    221,351       223,455  
 
           
Total liabilities and shareholders’ equity
  $ 374,414     $ 381,654  
 
           
The accompanying notes are an integral part of these financial statements.

 

4


Table of Contents

RADISYS CORPORATION
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY
(In thousands, unaudited)
                                                 
                    Accumulated                     Total  
    Common stock     Translation     Retained             Comprehensive  
    Shares     Amount     Adjustments     Earnings     Total     Loss (1)  
Balances, December 31, 2006
    21,835     $ 212,887     $ 4,013     $ 6,555     $ 223,455          
Shares issued pursuant to benefit plans
    100       1,307                   1,307          
Stock-based compensation associated with employee benefit plans
          2,231                   2,231          
Restricted shares granted, net
    17                                  
Currency translation adjustments
                38             38       38  
Cumulative effect of adjustment resulting from the adoption of FIN 48 (note 11)
                      (288 )     (288 )        
Net income (loss) for the period
                      (5,392 )     (5,392 )     (5,392 )
 
                                   
Balances, March 31, 2007
    21,952     $ 216,425     $ 4,051     $ 875     $ 221,351          
 
                                     
Comprehensive income (loss) for the three months ended March 31, 2007
                                          $ (5,354 )
 
                                             
 
(1)  
For the three months ended March 31, 2006, comprehensive income amounted to $1.5 million and consisted of net income for the period of $1.4 million and net losses from currency translation adjustments of $56 thousand.
The accompanying notes are an integral part of these financial statements.

 

5


Table of Contents

RADISYS CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
                 
    For the Three Months Ended  
    March 31,  
    2007     2006  
Cash flows from operating activities:
               
Net income (loss)
  $ (5,392 )   $ 1,426  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
               
Depreciation and amortization
    6,374       1,653  
Inventory valuation allowance
    1,813       1,338  
Deferred income taxes
    (820 )     401  
Stock-based compensation expense
    2,231       1,296  
Other
    52       (155 )
Changes in operating assets and liabilities:
               
Accounts receivable
    (7,285 )     (5,603 )
Other receivables
    (1,763 )     (200 )
Inventories
    (381 )     7,049  
Other current assets
    138       (93 )
Accounts payable
    (5,277 )     (1,781 )
Accrued restructuring
    (77 )     (556 )
Accrued interest payable
    311       309  
Accrued wages and bonuses
    (645 )     (1,296 )
Other accrued liabilities
    338       434  
 
           
Net cash provided by (used in) operating activities
    (10,383 )     4,222  
 
           
Cash flows from investing activities:
               
Proceeds from the sale of auction rate securities
    21,700       14,900  
Purchase of auction rate securities
    (8,600 )     (18,500 )
Capital expenditures
    (1,062 )     (1,307 )
Other
    (102 )     25  
 
           
Net cash provided by (used in) investing activities
    11,936       (4,882 )
 
           
Cash flows from financing activities:
               
Proceeds from issuance of common stock
    1,307       2,326  
 
           
Net cash provided by financing activities
    1,307       2,326  
 
           
Effect of exchange rate changes on cash
    37       81  
 
           
Net increase in cash and cash equivalents
    2,897       1,747  
Cash and cash equivalents, beginning of period
    23,734       90,055  
 
           
Cash and cash equivalents, end of period
  $ 26,631     $ 91,802  
 
           
The accompanying notes are an integral part of these financial statements.

 

6


Table of Contents

RADISYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1 — Significant Accounting Policies
RadiSys Corporation (the “Company” or “RadiSys”) has adhered to the accounting policies set forth in its Annual Report on Form 10-K for the year ended December 31, 2006 in preparing the accompanying interim consolidated financial statements. The preparation of these statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. Actual results could differ from those estimates. Additionally, the accompanying financial data as of March 31, 2007 and for the three months ended March 31, 2007 and 2006 has been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. However, the Company believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.
The financial information included herein reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the results for interim periods.
For the three months ended March 31, 2007, there have been no significant changes to these accounting policies.
Revenue Recognition
The Company recognizes revenue when the earnings process is complete, as evidenced by the following revenue recognition criteria: an agreement with the customer, fixed pricing, transfer of title and risk of loss and customer acceptance, if applicable, and that the collectibility of the resulting receivable is reasonably assured. When a sales arrangement contains multiple elements, such as hardware and software products, licenses and/or services, the Company allocates revenue to each element based on its relative fair value, or for software, based on vendor specific objective evidence of fair value under the residual method of accounting. Under this method, the total arrangement value is allocated first to undelivered elements, based on their fair values, with the remainder being allocated to the delivered elements. Where the fair value for an undelivered element cannot be determined, the Company defers revenue recognition for the delivered elements until the undelivered elements are delivered. The Company limits the amount of revenue recognition for delivered elements to the amount that is not contingent on the future delivery of products or services or subject to customer-specified return or refund privileges. The Company accounts for sales and other use taxes on a net basis in accordance with EITF Issue No. 06-3 “How Taxes Collected from Customers and Remitted to Governmental Authorities Should be Presented in the Income Statement.” Therefore, these taxes are excluded from revenue and cost of revenue in the Consolidated Statements of Operations.
Inventory Reserves
The Company records the inventory valuation allowance for estimated obsolete or unmarketable inventories as the difference between the cost of inventories and the estimated net realizable value based upon assumptions about future demand and market conditions. Factors influencing the provision include: changes in demand, rapid technological changes, product life cycle and development plans, component cost trends, product pricing, regulatory requirements effecting components, and physical deterioration. If actual market conditions are less favorable than those projected by management, additional provisions for inventory reserves may be required. The Company’s estimate for the allowance is based on the assumption that the Company’s customers comply with their current contractual obligations. The Company provides long-life support to its customers and therefore the Company has material levels of customer specific inventory. If the Company’s customers experience a financial hardship or if the Company experiences unplanned cancellations of customer contracts, the current provision for the inventory reserves may be inadequate. Additionally, the Company may incur additional expenses associated with any non-cancelable purchase obligations to its suppliers if they provide customer-specific components.

 

7


Table of Contents

Adverse Purchase Commitments
The Company is contractually obligated to reimburse its contract manufacturers for the cost of excess inventory used in the manufacture of the Company’s products, for which there is no alternative use. This liability, referred to as adverse purchase commitments, is provided for in other accrued liabilities in the accompanying balance sheets. Estimates for adverse purchase commitments are derived from reports received on a quarterly basis from the Company’s contract manufacturers. Increases to this liability are charged to cost of goods sold. When and if the Company takes possession of inventory reserved for in this liability, the liability is transferred from other liabilities to our excess and obsolete inventory valuation allowance. Adverse purchase commitments amounted to $1.8 million and $1.9 million at March 31, 2007 and December 31, 2006, respectively. For the three months ended March 31, 2007 and 2006, the Company recorded a net provision for adverse purchase commitments of $488 thousand and $424 thousand, respectively.
Guarantees and Indemnification Obligations
FASB FIN No. 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others,” an interpretation of SFAS No. 5, 57, and 107 and rescission of FASB Interpretation No. 34, requires that a guarantor recognize, at the inception of a guarantee, a liability for the fair value of the obligation undertaken by issuing the guarantee and requires additional disclosures to be made by a guarantor in its interim and annual financial statements about its obligations under certain guarantees it has issued. The following is a summary of the agreements that the Company has determined are within the scope of FIN No. 45.
As permitted under Oregon law, the Company has agreements whereby it indemnifies its officers, directors and certain finance employees for certain events or occurrences while the officer, director or employee is or was serving in such capacity at the request of the Company. The term of the indemnification period is for the officer’s, director’s or employee’s lifetime. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has a director and officer insurance policy that limits its exposure and enables the Company to recover a portion of any future amounts paid. As a result of the Company’s insurance policy coverage, management believes the estimated fair value of these indemnification agreements is minimal. Accordingly, the Company has not recorded any liabilities for these agreements as of March 31, 2007.
The Company enters into standard indemnification agreements in its ordinary course of business. Pursuant to these agreements, the Company indemnifies, holds harmless and agrees to reimburse the indemnified party for losses suffered or incurred by the indemnified party, generally our business partners or customers, in connection with patent, copyright or other intellectual property infringement claims by any third party with respect to our current products, as well as claims relating to property damage or personal injury resulting from the performance of services by us or our subcontractors. The maximum potential amount of future payments we could be required to make under these indemnification agreements is generally limited. Historically, our costs to defend lawsuits or settle claims relating to such indemnity agreements have been minimal and accordingly management believes the estimated fair value of these agreements is negligible.
The Company provides for the estimated cost of product warranties at the time it recognizes revenue. Products are generally sold with warranty coverage for a period of 24 months after shipment. Parts and labor are covered under the terms of the warranty agreement. The workmanship of our products produced by contract manufacturers is covered under warranties provided by the contract manufacturer for a specific period of time ranging from 12 to 15 months. The warranty provision is based on historical experience by product family. The Company engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers; however, ongoing failure rates, material usage and service delivery costs incurred in correcting product failure, as well as specific product class failures out of the Company’s baseline experience affect the estimated warranty obligation. If actual product failure rates, material usage or service delivery costs differ from estimates, revisions to the estimated warranty liability would be required.
The following is a summary of the change in the Company’s warranty liability for the three months ended March 31, 2007 and 2006 (in thousands):
                 
    For the Three Months Ended  
    March 31,  
    2007     2006  
Warranty liability balance, beginning of the period
  $ 2,000     $ 2,124  
Product warranty accruals
    800       860  
Utilization of accrual
    (706 )     (842 )
 
           
Warranty liability balance, end of the period
  $ 2,094     $ 2,142  
 
           

 

8


Table of Contents

The warranty liability balance is included in other accrued liabilities in the accompanying consolidated balance sheets as of March 31, 2007 and December 31, 2006.
On November 22, 2005, the Company received a notice from a customer claiming a breach of a software maintenance support contract and claiming damages. In the first quarter of 2007, the Company settled the claim for approximately $90 thousand including a $25 thousand cash payment.
Recent Accounting Pronouncements
In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities—Including an Amendment of FASB Statement No. 115” (“SFAS 159”). SFAS 159 expands the use of fair value accounting but does not affect existing standards, which require assets or liabilities to be carried at fair value. Under SFAS 159, a company may elect to use fair value to measure accounts and loans receivable, available-for-sale and held-to-maturity securities, equity method investments, accounts payable, guarantees and issued debt. Other eligible items include firm commitments. SFAS 159 is effective for fiscal years ending after November 15, 2007. The Company has completed its evaluation of the impact of SFAS 159 and has determined not to adopt its provisions.
Note 2 — Stock-based Compensation
For the three months ended March 31, 2007 and 2006, stock-based compensation was recognized and allocated as follows (in thousands):
                 
    For the Three Months Ended  
    March 31,  
    2007     2006  
Cost of sales
  $ 262     $ 218  
Research and development
    602       388  
Selling, general and administrative
    1,367       690  
 
           
 
    2,231       1,296  
 
           
Note 3 — Investments
Short-term and long-term investments consisted of the following (in thousands):
                 
    March 31,     December 31,  
    2007     2006  
Short-term investments, classified as available-for-sale
  $ 89,150     $ 102,250  
 
           
Long-term held-to-maturity investments
  $ 10,000     $ 10,000  
 
           
The Company invests excess cash in debt instruments of the U.S. Government and its agencies, high-quality corporate issuers and municipalities. The Company’s investments in the debt instruments of municipalities primarily consist of investments in auction rate securities. Auction rate securities have been classified as available-for-sale short-term investments. Available-for-sale securities are recorded at fair value, and unrealized holding gains and losses are recorded, net of tax, as a separate component of accumulated other comprehensive income. For the three months ended March 31, 2007 and 2006, the Company did not recognize any gains or losses on the sale of available-for-sale investments as the fair value of these investments approximated their carrying value. The Company incurred no unrealized gains or losses on investments classified as available-for-sale as of March 31, 2007 or December 31, 2006. The Company’s investment policy requires that the total investment portfolio, including cash and investments, not exceed a maximum weighted-average maturity of 18 months. In addition, the policy mandates that an individual investment must have a maturity of less than 36 months, with no more than 20% of the total portfolio exceeding 24 months. As of March 31, 2007, the Company was in compliance with its investment policy.
Note 4 — Accounts Receivable and Other Receivables
Accounts receivable consists of trade accounts receivable. Accounts receivable balances consisted of the following (in thousands):
                 
    March 31,     December 31,  
    2007     2006  
Accounts receivable, gross
  $ 50,696     $ 43,407  
Less: allowance for doubtful accounts
    (856 )     (858 )
 
           
Accounts receivable, net
  $ 49,840     $ 42,549  
 
           

 

9


Table of Contents

The Company recorded no additional provisions for allowance for doubtful accounts during the three months ended March 31, 2007 and 2006.
As of March 31, 2007 and December 31, 2006, the balance in other receivables was $5.5 million and $3.8 million, respectively. Other receivables consisted primarily of non-trade receivables, including receivables for inventory sold to our contract manufacturing partners and sub-lease billings. Sales to the Company’s contract manufacturing partners are based on terms and conditions similar to the terms offered to the Company’s regular customers. There is no revenue recorded associated with non-trade receivables.
Note 5 — Inventories
Inventories consisted of the following (in thousands):
                 
    March 31,     December 31,  
    2007     2006  
Raw materials
  $ 34,536     $ 32,034  
Work-in-process
    3,617       3,138  
Finished goods
    5,624       8,624  
 
           
 
    43,777       43,796  
Less: inventory valuation allowance
    (10,025 )     (8,612 )
 
           
Inventories, net
  $ 33,752     $ 35,184  
 
           
During the three months ended March 31, 2007 and 2006, the Company recorded provisions for excess and obsolete inventory of $1.8 million and $1.3 million, respectively.
Note 6 — Long-lived Assets Held for Sale
Beginning in 2001, RadiSys made it part of its strategic plan to significantly reduce its costs. As part of this plan, RadiSys began in 2004 to outsource the manufacture of most of its products. Through various restructuring activities, facilities requirements for manufacturing and other activities in the Hillsboro, Oregon location have decreased significantly. As a result, management decided to transfer operations currently located in one of the Company’s buildings in Hillsboro, Oregon (“DC3 building”) to its other building located in Hillsboro, Oregon and its contract manufacturing partners.
In January 2006, RadiSys vacated the DC3 building and put it and the surrounding land, which had previously been held for future expansion, on the market for sale. The assets held for sale had a recorded value of $3.5 million, which included land with a value of $2.2 million, building and building improvements with a net value of $1.3 million, and machinery and equipment with a net value of $38 thousand. The Company classified this facility in net assets held for sale as of January 31, 2006, and as a result ceased depreciation of these assets.
Note 7 — Accrued Restructuring and Other Charges
Accrued restructuring and other charges consisted of the following (in thousands):
                 
    March 31,     December 31,  
    2007     2006  
Fourth quarter 2006 restructuring charge
  $ 240     $ 329  
First quarter 2007 restructuring charge
    12        
 
           
Total
  $ 252     $ 329  
 
           
The Company evaluates the adequacy of the accrued restructuring and other charges on a quarterly basis. As a result, the Company records certain reclassifications and reversals to the accrued restructuring and other charges based on the results of the evaluation. The total accrued restructuring and other charges for each restructuring event are not affected by reclassifications. Reversals are recorded in the period in which the Company determines that expected restructuring and other obligations are less than the amounts accrued.

 

10


Table of Contents

Fourth Quarter 2006 Restructuring
During the fourth quarter of 2006, the Company initiated a restructuring plan that included the elimination of 12 positions primarily supporting the Company’s contract manufacturing operations as a result of the termination of our relationship with one of our contract manufacturers in North America. The restructuring plan also includes closing our Charlotte, North Carolina manufacturing support office. We expect this workforce reduction and office closure to be completed by September 30, 2007.
The following table summarizes the changes to the fourth quarter 2006 restructuring costs (in thousands):
         
    Employee  
    Termination and  
    Related Costs  
Restructuring and other costs
  $ 329  
 
     
Balance accrued as of December 31, 2006
  $ 329  
 
     
Additions
  $ 61  
Expenditures
    (50 )
Reversals
    (100 )
 
     
Balance accrued as of March 31, 2007
  $ 240  
 
     
During the three months ended March 31, 2007, we incurred additional severance and other employee-related separation costs of $61 thousand offset by reversals of $100 thousand associated with three employees that found new positions within the Company.
First Quarter 2007 Restructuring
During the first quarter of 2007, the Company incurred employee-related expenses associated with certain engineering realignments. The costs incurred in this restructuring event are associated with employee termination benefits, including severance and medical benefits. All restructuring activities are expected to be completed by June 30, 2007.
The following table summarizes the changes to the first quarter 2007 restructuring costs (in thousands):
         
    Employee  
    Termination and  
    Related Costs  
Restructuring and other costs
  $ 120  
Additions
    7  
Expenditures
    (115 )
 
     
Balance accrued as of March 31, 2007
  $ 12  
 
     
Note 8 — Short-Term Borrowings
During the quarter ended March 31, 2006, the Company transferred its $20.0 million line of credit facility from its commercial bank to an investment bank. This line of credit facility has an interest rate based on the 30-day London Inter-Bank Offered Rate (“LIBOR”) plus 0.75%. The line of credit is collateralized by the Company’s non-equity investments. At March 31, 2007, the Company had a standby letter of credit outstanding related to one of its medical insurance carriers for $105 thousand. The market value of non-equity investments must exceed 125.0% of the borrowed facility amount, and the investments must meet specified investment grade ratings.
As of March 31, 2007 and December 31, 2006, there were no outstanding balances on the standby letter of credit or line of credit and we were in compliance with all debt covenants.
Note 9 — Long-Term Liabilities
Convertible Senior Notes
During November 2003, the Company completed a private offering of $100 million in aggregate principal amount of 1.375% convertible senior notes due November 15, 2023 to qualified institutional buyers. The discount at issuance on the convertible senior notes amounted to $3 million.

 

11


Table of Contents

Convertible senior notes are unsecured obligations convertible into the Company’s common stock and rank equally in right of payment with all existing and future obligations that are unsecured and unsubordinated. Interest on the convertible senior notes accrues at 1.375% per year and is payable semi-annually on May 15 and November 15. The notes are convertible, at the option of the holder, at any time on or prior to maturity under certain circumstances unless previously redeemed or repurchased, into shares of the Company’s common stock at a conversion price of $23.57 per share, which is equal to a conversion rate of 42.4247 shares per $1,000 principal amount of notes. The notes are convertible if (i) the closing price of the Company’s common stock on the trading day prior to the conversion date reaches 120% or more of the conversion price of the notes on such trading date, (ii) the trading price of the notes falls below 98% of the conversion value or (iii) certain other events occur. Upon conversion, the Company will have the right to deliver, in lieu of common stock, cash or a combination of cash and common stock. The Company may redeem all or a portion of the notes at its option on or after November 15, 2006 but before November 15, 2008 provided that the closing price of the Company’s common stock exceeds 130% of the conversion price for at least 20 trading days within a period of 30 consecutive trading days ending on the trading day before the date of the notice of the provisional redemption. On or after November 15, 2008, the Company may redeem the notes at any time. On November 15, 2008, November 15, 2013, and November 15, 2018, holders of the convertible senior notes will have the right to require the Company to purchase, in cash, all or any part of the notes held by such holder at a purchase price equal to 100% of the principal amount of the notes being purchased, together with accrued and unpaid interest and additional interest, if any, up to but excluding the purchase date. The accretion of the discount on the notes is calculated using the effective interest method.
As of March 31, 2007 and December 31, 2006, the Company had outstanding convertible senior notes with a face value of $100 million and a book value of $97.4 million, net of unamortized discount of $2.6 million. Amortization of the discount on the convertible senior notes was $34 thousand and $33 thousand for the three months ended March 31, 2007 and 2006, respectively. The estimated fair value of the convertible senior notes was $96.6 million at March 31, 2007 and December 31, 2006.
Convertible Subordinated Notes
During August 2000, the Company completed a private offering of $120 million in aggregate principal amount of 5.5% convertible subordinated notes due August 15, 2007 to qualified institutional buyers. The discount at issuance on the convertible subordinated notes amounted to $3.6 million.
Convertible subordinated notes are unsecured obligations convertible into the Company’s common stock and are subordinated to all present and future senior indebtedness of the Company. Interest on the convertible subordinated notes accrues at 5.5% per year and is payable semi-annually on February 15 and August 15. The notes are convertible, at the option of the holder, at any time on or before maturity, unless previously redeemed or repurchased, into shares of the Company’s common stock at a conversion price of $67.80 per share, which is equal to a conversion rate of 14.7484 shares per $1,000 principal amount of notes. If the closing price of the Company’s common stock equals or exceeds 140% of the conversion price for at least 20 trading days within a period of 30 consecutive trading days ending on the trading day before the date on which a notice of redemption is mailed, then the Company may redeem all or a portion of the notes at its option at a redemption price equal to the principal amount of the notes plus a premium (which declines annually on August 15 of each year), together with accrued and unpaid interest to, but excluding, the redemption date. The accretion of the discount on the notes is calculated using the effective interest method.
For the year ended December 31, 2006, the Company repurchased $100 thousand principal amount of the convertible subordinated notes for $100 thousand and recorded a loss of approximately $1 thousand.
As of March 31, 2007 and December 31, 2006 the Company had outstanding convertible subordinated notes with a face value of $2.4 million and a book value of $2.4 million, net of amortized discount of $5 thousand and $8 thousand, respectively. Amortization of the discount on the convertible subordinated notes was $3 thousand for the three months ended March 31, 2007 and 2006. The estimated fair value of the convertible subordinated notes was $2.4 million at March 31, 2007 and December 31, 2006.

 

12


Table of Contents

The aggregate maturities of long-term liabilities for each of the years in the five year period ending December 31, 2011 and thereafter are as follows (in thousands):
                 
    Convertible     Convertible  
    Senior     Subordinated  
For the Years Ending December 31,   Notes     Notes  
2007 (remaining nine months)
  $     $ 2,418  
2008 (A)
    100,000        
2009
           
2010
           
2011
           
Thereafter
           
 
           
 
    100,000       2,418  
Less: unamortized discount
    (2,554 )     (5 )
Less: current portion
          2,413  
 
           
Long-term liabilities
  $ 97,446     $  
 
           
 
(A)  
The Company may redeem the convertible senior notes at any time on or after November 15, 2008. On November 15, 2008, November 15, 2013, and November 15, 2018, holders of the convertible senior notes will have the right to require the Company to purchase, in cash, all or any part of the notes held by such holder at a purchase price equal to 100% of the principal amount of the notes being purchased, together with accrued and unpaid interest and additional interest, if any, up to but excluding the purchase date.
Note 10 — Basic and Diluted Income (Loss) per Share
A reconciliation of the numerator and the denominator used to calculate basic and diluted income per share is as follows (in thousands, except per share amounts):
                 
    For the Three Months Ended  
    March 31,  
    2007     2006  
Numerator — Basic
               
Net income (loss), basic
  $ (5,392 )   $ 1,426  
 
           
Numerator — Diluted
               
Net income (loss), basic
    (5,392 )     1,426  
Interest on convertible notes, net of tax benefit (A)
          245  
 
           
Net income (loss), diluted
  $ (5,392 )   $ 1,671  
 
           
Denominator — Basic
               
Weighted average shares used to calculate income per share, basic
    21,682       20,699  
 
           
Denominator — Diluted
               
Weighted average shares used to calculate income per share , basic
    21,682       20,699  
Effect of convertible notes (A)
          4,243  
Effect of dilutive stock options, ESPP, and unvested restricted stock (B)
          607  
 
           
Weighted average shares used to calculate income per share, diluted
    21,682       25,549  
 
           
Net income (loss) per share:
               
Basic
  $ (0.25 )   $ 0.07  
 
           
Diluted (A)
  $ (0.25 )   $ 0.07  
 
           
 
(A)  
Interest on the convertible senior notes and related as-if converted shares were excluded from the calculation if the effect would be anti-dilutive. As of March 31, 2007, the as-if converted shares associated with the convertible subordinated notes were excluded from the calculation as the effect would be anti-dilutive. For the three months ended March 31, 2007 and 2006, the total number of as-if converted shares excluded from the calculation associated with the convertible subordinated notes was 36 thousand and 37 thousand. As of March 31, 2007, the total number of as-if converted shares associated with the convertible senior notes was 4.2 million.
 
(B)  
For the three months ended March 31, 2007, options amounting to 3.0 million shares were excluded from the calculation as the Company was in a loss position. For the three months ended March 31, 2006, options amounting to 1.9 million shares were excluded from the calculation as exercise prices were higher than the average market price of the common shares; therefore, the effect would be anti-dilutive.
Note 11 — Income Taxes
The Company’s effective tax rate for the three months ended March 31, 2007 and 2006 differs from the statutory rate primarily due to the benefits of lower tax rates on earnings of foreign subsidiaries, the federal research and development tax credit, the SFAS 123R adjustments, the amortization of goodwill for tax purposes, and the discrete item related to the additional accrual of interest and penalties for uncertain tax positions.

 

13


Table of Contents

The expensing of stock options will create differences in book and taxable income on both a permanent and temporary basis. We are projecting a tax effected permanent difference of approximately $1.9 million attributable to statutory options and stock option expense related to all non U.S. employees for the year ending 2007. The annual effective tax rate impact for this permanent difference is projected to be approximately 10.1%.
In June 2006, the FASB issued FASB Interpretation No. 48 “Accounting for Uncertainty in Income Taxes — an interpretation of FASB Statement 109” (“FIN 48”). FIN 48 establishes a single model to address accounting for uncertain tax positions. FIN 48 clarifies the accounting for income taxes by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. FIN 48 also provides guidance on derecognition, measurement classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company adopted the provisions of FIN 48, on January 1, 2007. Upon adoption, the Company increased its reserves for uncertain tax positions by $146 thousand, largely due to the additional accrual of interest and penalties. The adoption adjustment was recorded as a cumulative effect adjustment to shareholders’ equity. This increase was accounted for as a decrease of $288 thousand to the beginning balance of retained earnings partially offset by a decrease of $142 thousand to goodwill related to the acquisition of Convedia Corporation (“Convedia”). As of the date of adoption, the Company’s unrecognized tax benefits totaled $2.0 million. Of this total, $1.5 million represents the amount of unrecognized tax benefits that, if recognized, will favorably affect the effective tax rate. The remaining $474 thousand, if recognized, will result in the reduction of goodwill.
The Company and its subsidiaries are subject to federal income tax as well as income tax of multiple state and foreign jurisdictions. The statute of limitations is closed for all federal, state and foreign income tax returns filed before 2003, 2002 and 2001, respectively. However, to the extent allowed by law, the taxing authorities may have the right to examine prior periods where net operating losses and credits were generated and carried forward, and make adjustments up to the net operating loss and credit carryforward amounts.
The Company is not currently under Internal Revenue Service (IRS) examination. During 2005, the Company settled an IRS tax examination related to the 1996 through 2002 tax years. In the first quarter of 2007, the state of Texas tax authorities commenced audits of the 2002 through 2005 years. In the fourth quarter of 2006, the German tax authorities commenced audits of 2002 through 2004 years. To date, there are no proposed adjustments that will have a material impact on the Company’s position or results of operations. The Company is not currently under examination in any other states or foreign jurisdictions.
The Company’s ongoing practice is to recognize potential accrued interest and penalties related to unrecognized tax benefits within its global operations in income tax expense. In conjunction with the adoption of FIN 48, the Company increased the accrual for interest and penalties by an additional $40 thousand to $511 thousand on January 1, 2007 which is included as a component of the $2.0 million unrecognized tax benefit noted above. To the extent that interest and penalties are not assessed with respect to the uncertain tax positions, $404 thousand of this total will be reflected as a reduction of the overall income tax provision. The remaining $107 thousand, if not assessed, will result in the reduction of goodwill. During the three months ended March 31, 2007, the Company recognized approximately $58 thousand in potential interest and penalties associated with uncertain tax positions.
The Company does not anticipate that the total unrecognized tax benefits will significantly change due to the settlement of examinations prior to December 31, 2007 or March 31, 2008. The unrecognized tax benefits anticipated to be recognized due to the expiration of statute of limitations within twelve months of the date of FIN 48 adoption are $1.3 million. The unrecognized tax benefits anticipated to be recognized within twelve months primarily relates to foreign subsidiaries operations. Additionally, the unrecognized tax benefits anticipated to be recognized due to the expiration of statute of limitations prior to March 31, 2008 are $1.3 million.
Note 12 — Segment Information
The Company has adopted SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information.” SFAS No. 131 establishes standards for the reporting by public business enterprises of information about operating segments, products and services, geographic areas, and major customers. The method for determining what information to report is based upon the way that management organizes the segments within the Company for making operating decisions and assessing financial performance.
The Company is one operating segment according to the provisions of SFAS No. 131.

 

14


Table of Contents

Revenues on a product and services basis are as follows (in thousands):
                 
    For the Three Months Ended  
    March 31,  
    2007     2006  
Hardware
  $ 63,151     $ 63,711  
Software royalties and licenses
    2,452       1,122  
Software maintenance
    236       540  
Engineering and other services
    1,014       438  
 
           
Total revenues
  $ 66,853     $ 65,811  
 
           
Generally, the Company’s customers are not the end-users of its products. The Company ultimately derives its revenues from two end markets as follows (in thousands):
                 
    For the Three Months Ended  
    March 31,  
    2007     2006  
Communications Networking
  $ 48,834     $ 48,836  
Commercial Systems
    18,019       16,975  
 
           
Total revenues
  $ 66,853     $ 65,811  
 
           
Information about the Company’s geographic revenues and long-lived assets by geographical area is as follows (in thousands):
Geographic Revenues
                 
    For the Three Months Ended  
    March 31,  
    2007     2006  
United States
  $ 22,789     $ 18,213  
Other North America
    2,365       2,606  
 
           
North America
    25,154       20,819  
Europe, the Middle East and Africa (“EMEA”)
    27,397       34,405  
Asia Pacific
    14,302       10,587  
 
           
Total
  $ 66,853     $ 65,811  
 
           
Long-lived assets by Geographic Area
                 
    March 31,     December 31,  
    2007     2006  
Property and equipment, net
               
United States
  $ 7,744     $ 7,881  
Other North America
    1,079       1,096  
EMEA
    114       143  
Asia Pacific
    1,830       1,955  
 
           
Total
  $ 10,767     $ 11,075  
 
           
Goodwill
               
United States
  $ 27,463     $ 27,463  
Other North America
    39,578       39,720  
 
           
Total
    67,041       67,183  
 
           
Intangible assets, net
               
United States
    1,301       1,434  
Other North America
    16,253       18,416  
EMEA
    21,124       23,085  
 
           
Total
  $ 38,678     $ 42,935  
 
           
For the three months ended March 31, 2007 and 2006, only one customer, Nokia, accounted for more than 10% of total revenues. This customer accounted for 33.0% and 41.4% of total revenue for the three months ended March 31, 2007 and 2006, respectively.

 

15


Table of Contents

As of March 31, 2007 and December 31, 2006, the following two customers accounted for more than 10% of accounts receivable:
                 
    March 31,     December 31,  
    2007     2006  
Nokia
    37.8 %     24.4 %
Nortel
    *       10.2 %
 
*  
Accounted for less than 10% of accounts receivable.
Note 13 — Legal Proceedings
In the normal course of business, the Company periodically becomes involved in litigation. As of March 31, 2007, in the opinion of management, RadiSys had no pending litigation that would reasonably be expected to have a material adverse effect on the Company’s financial position, results of operations or cash flows.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Introduction and Overview
RadiSys Corporation is a leading provider of embedded advanced solutions for the communications networking and commercial systems markets. Through innovative product planning, intimate customer collaboration, and combining innovative technologies and industry leading architecture, we help original equipment manufacturers (“OEMs”), systems integrators and solution providers bring better products to market faster and more economically. Our products include embedded boards, application enabling platforms and turn-key systems, which are used in today’s complex computing, processing and network intensive applications. Unless context otherwise requires, or as otherwise indicated, “we,” “us,” “our” and similar terms, as well as references to the “Company” and “RadiSys” refer to RadiSys Corporation, and unless the context requires otherwise, includes all of our consolidated subsidiaries.
Our Strategy
Our strategy is to provide customers with standards-based advanced embedded solutions in our target markets. We believe this strategy enables our customers to focus their resources and development efforts on their key areas of competency allowing them to provide higher value systems with a time-to-market advantage and a lower total cost of ownership. Historically, system makers had been largely vertically integrated, developing most, if not all, of the functional building blocks of their systems. System makers are now more focused on their core expertise, such as specific application software, and are looking for partners like RadiSys to provide them with standards-based, merchant-supplied building blocks for a growing number of processing and networking functions.
Our Markets
We provide application enabling solutions to the following two distinct markets:
   
Communications Networking — The communications networking market consists primarily of networking infrastructure and applications for deployment within our wireless and IP networking and messaging markets. Applications in these markets include 2, 2.5 and 3G wireless infrastructure products, IP media server platforms, packet based switches, unified messaging solutions, Internet Protocol (IP)-based Private Branch Exchange (PBX) systems, voice messaging, multimedia conferencing, data centers, network access, security and switching applications.
 
   
Commercial Systems — The commercial systems market includes the following sub-markets: medical systems, test and measurement equipment, transaction terminals and industrial automation equipment. Examples of products which incorporate our commercial embedded solutions include ultrasound equipment, X-Ray, Magnetic Resonance Imaging (MRI), immunodiagnostics and hematology systems, CAT Scan (CT) imaging equipment, network and production test equipment, consumer transaction terminals, semiconductor manufacturing equipment and electronics assembly equipment.
Our Market Drivers
We believe there are a number of fundamental drivers for growth in the embedded solutions market, including:
   
Increasing desire by OEMs to utilize standards-based, merchant-supplied modular building blocks and platforms to develop their new systems. We believe OEMs are combining their internal development efforts with merchant-supplied building blocks and platforms from partners like RadiSys to deliver a larger number of more valuable new products to market faster at a lower total cost of ownership.

 

16


Table of Contents

   
Increasing usage levels of widely adopted technologies such as Ethernet, IP, Linux, media processing and CPU, GPU and NPU processors to provide programmable, intelligent and networked functionality to a wide variety of applications, including wireless, wireline and data communications, network security, image processing, transaction and monitoring and control.
 
   
Increasing demand for standards-based solutions, such as Advanced Telecommunications Architecture (“ATCA”), Session Initiation Protocol (“SIP”), IP Multimedia Subsystem (“IMS”) and Computer-on-Module Express (“COM Express”), that motivates system makers to take advantage of proven and validated standards-based products.
In the following discussion of our financial condition and results of operations, we intend to provide information that will assist in understanding our consolidated financial statements, the changes in certain key items in those financial statements from year to year, and the primary factors that accounted for those changes. This discussion should be read in conjunction with our consolidated financial statements and the related notes included elsewhere in this filing and in our annual report on Form 10-K for the year ended December 31, 2006.
Certain statements made in this section of the report are forward-looking statements. Please see the information contained herein under the sections entitled “Forward-looking Statements” and “Risk Factors.”
Overview
In 2006, we announced nine new products in our Promentum™ family of ATCA solutions. Specifically, we announced two new products based on the latest OCTEON processors from Cavium Networks. The new ATCA and AMC solutions provide high density Gigabit Ethernet interfaces with sophisticated dataplane hardware acceleration. These products will help equipment manufacturers reduce research, development and engineering (“R&D”) costs while accelerating the introduction of high performance products such as Radio Network Controllers, Session Border Controllers, Media Gateways, Edge Routers and Security Gateways. Our new AMC-7211 product provides power efficient packet and security processing for customers requiring AMC modules for their ATCA and MicroTCA platforms. The ATCA-7200 is a high performance modular gigabit line card equipped with up to four Cavium OCTEON Plus processor AMCs. As of this filing, we have begun shipping evaluation units.
During the first quarter of 2007, we and Aricent, a full-service, full-spectrum communications software company, demonstrated an ATCA hardware and software platform designed specifically for WiMAX networks. The solution features the Aricent SigASN WiMAX Gateway software running on the Promentum ATCA SYS 6010, which is the industry’s first and only generally available 10 Gigabit common managed platform for high-bandwidth network element and data plane applications. Our 10 Gigabit ATCA platforms are invaluable to equipment manufacturers developing complex network elements such as WiMAX ASN Gateways, 3G Radio Network and Base Station Controllers, IPTV infrastructure and IP IMS compliant media gateways, application servers and media servers.
In addition to our new ATCA offerings in 2006, we announced the Procelerant™ RMS420, a 4U high performance embedded server with two dual-core processors and the Procelerant™ CE945GM dual-core COM Express module. As of March 31, 2007, both products began shipping.
During the first quarter of 2007, we announced the availability of two new PCI Computer Manufacturers Group (PICMG) Compatible COM Express modules and a quad core embedded server that delivers unsurpassed performance and functionality. The Intel Core 2 Duo processor-based COM Express module coupled with dual channel memory brings maximum computing performance to imaging, gaming, and test and measurement devices that require the smallest COM Express form factor on the market. The second COM Express module that was announced features an extended temperature range COM Express module and fills a highly desired need for in-flight infotainment, industrial and military applications. The quad core server with Intel Core microarchitecture increases the performance of imaging and signaling applications five to seven -fold compared to servers available just 12 months ago.
We also announced a partnership with VirtualLogix, the Real-Time Virtualization company, to deliver a real-time development kit that enables embedded systems designers to combine Linux and our OS-9 real-time operating system onto a single platform. This will enable our customers to improve performance, reduce power consumption and consolidate multiple single core designs onto a single, integrated platform.
In the third quarter of 2006, we completed the acquisition of Convedia and entered the media server market with a portfolio of media server products. Included in this portfolio are our newest media servers, the CMS-3000 and CMS-9000, which are optimized for IMS network deployments have successfully completed field trials and are now generally available to our larger customer base.

 

17


Table of Contents

During the first quarter of 2007, we announced that we are working closely with Huawei Technologies to deliver IMS solutions that reduce the cost and increase the performance of next generation networks. The Huawei Next Generation Network (NGN) solution and the fixed and mobile convergent IMS solutions incorporate MRS products based on our Media Servers. These solutions are now being marketed and sold into Huawei’s extensive global customer base.
Total revenue was $66.9 million and $65.8 million for the three months ended March 31, 2007 and 2006, respectively. Backlog was approximately $28.2 million and $21.7 million at March 31, 2007 and December 31, 2006, respectively. Backlog includes all purchase orders scheduled for delivery within 12 months. The increase in revenues for the three months ended March 31, 2007 compared to the same period in 2006 was due to higher levels of revenue within our test and measurement submarket as well as the addition of media server revenues partially offset by lower wireless revenues.
Net loss was $5.4 million for the three months ended March 31, 2007 compared to net income of $1.4 million for the three months ended March 31, 2006. Net loss per share was $0.25 for the three months ended March 31, 2007 compared to net income per share of $0.07 basic and diluted for the same period in 2006. Net income has decreased from 2006 to 2007, due primarily to the purchase accounting charges incurred in connection with the acquisition of Convedia, including $4.1 million of intangible amortization and $467 thousand of deferred compensation expenses. The decrease is also due to increased stock-based compensation expense of $935 thousand attributable to the diminishing benefit associated with the 2004 acceleration of employee stock options.
Cash and cash equivalents and investments amounted to $125.8 million and $136.0 million at March 31, 2007 and December 31, 2006, respectively. The decrease in cash and cash equivalents and investments during the three months ended March 31, 2007, was primarily due to the remaining payments associated with our inventory build last quarter as well as shipment linearity within the quarter. Management believes that available cash and investment balances, and short-term borrowings will be sufficient to fund our operating liquidity needs for the short-term and long-term.
Critical Accounting Policies and Estimates
The Company reaffirms its critical accounting policies and use of estimates as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2006. There have been no significant changes during the three months ended March 31, 2007 to the items that we disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended December 31, 2006.
Results of Operations
The following table sets forth certain operating data as a percentage of revenues for the three months ended March 31, 2007 and 2006.
                 
    For the Three Months Ended  
    March 31,  
    2007     2006  
Revenues
    100.0 %     100.0 %
Cost of sales
    71.2       73.1  
 
           
Gross margin
    28.8       26.9  
Research and development
    16.1       13.9  
Selling, general, and administrative
    17.1       12.4  
Intangible assets amortization
    6.4       0.5  
Restructuring and other charges (reversals)
    0.1       0.1  
 
           
Income from operations
    (10.9 )     0.0  
Interest expense
    (0.6 )     (0.6 )
Interest income
    2.4       3.4  
Other (expense) income, net
    (0.1 )     0.0  
 
           
Income (loss) before income tax provision (benefit)
    (9.2 )     2.8  
Income tax provision (benefit)
    (1.2 )     0.6  
 
           
Net income (loss)
    (8.0 )%     2.2 %
 
           

 

18


Table of Contents

Comparison of Three Months Ended March 31, 2007 and 2006
Revenues. Revenues increased by $1.0 million or 1.6%, from $65.8 million in the three months ended March 31, 2006 to $66.9 million in the three months ended March 31, 2007. The increase in revenues for the three months ended March 31, 2007 compared to the same period in 2006 is primarily due to an increase in revenues in the commercial systems market of $1.0 million.
Revenues in the commercial systems market increased in the three months ended March 31, 2007 compared to the same period in 2006, primarily due to increases within the test and measurement and industrial automation submarkets partially offset by declines in our transaction terminal submarket. The increase in revenues from the test and measurement submarket was attributable to design wins that have ramped into production in the latter half of 2006. The decrease in revenues attributable to the transaction terminal market was primarily due to design wins nearing the end of their life cycle.
Revenues in the communications networking market remained flat in the three months ended March 31, 2007 compared to the same periods in 2006 due to lower wireless revenues offset by the addition of media server revenues.
Given the dynamics of these markets, we may experience general fluctuations in the percentage of revenue attributable to each market and, as a result, the quarter to quarter comparisons of our markets often are not indicative of overall economic trends affecting the long-term performance of our markets. We currently expect that both markets will continue to represent a significant portion of total revenues. Currently, our standards-based products do not make up a significant percentage of our total revenues, however, we believe design wins associated with these products will begin to ramp into production in 2008 based on the timing of our customers’ next generation system deployments.
From a geographic perspective, for the three months ended March 31, 2007 compared to the same period in 2006, revenues as measured by destination in the North American and Asia Pacific regions increased by $4.3 million and $3.7 million, respectively, offset by decreased revenues in the EMEA region $7.0 million. The increase in the North American region is primarily due to the addition of media server revenues. The increase in the Asia Pacific region is primarily due to existing multinational customers requesting the delivery of products directly into the Asia Pacific region. The decrease in the EMEA region revenues is primarily due to lower wireless revenues. We currently expect continued fluctuations in the percentage of revenue from each geographic region. Additionally, we expect revenues outside of the US to remain a significant portion of our revenues.
Gross Margin. Gross margins as a percentage of revenues were 28.8% and 26.9% for the three months ended March 31, 2007 and 2006, respectively. The increase in gross margin as a percentage of revenues for the three months ended March 31, 2007 compared to the same period in 2006 was primarily attributable to product mix with the addition of our media server business within our communications networking market. This is partially offset by an increase in our excess and obsolete accrual primarily due to decreased demand for end-of-life products as well as inventory rework costs. We currently expect our gross margin percentage to be lower in the second quarter of 2007 due to costs associated with the remaining transitions from our North Carolina manufacturing partner to our plant in Hillsboro along with unfavorable change in our product mix. However, we do expect gross margins to be higher in the second half of 2007.
Research and Development. R&D expenses consist primarily of salaries, bonuses and benefits for product development staff, and cost of design and development supplies and equipment, net of reimbursements for nonrecurring engineering services. R&D expenses increased $1.7 million, or 18.1%, from $9.1 million for the three months ended March 31, 2006 to $10.8 million for the three months ended March 31, 2007. This increase is primarily due to the addition of our media server business, as well as an additional $214 thousand of stock-based compensation expense compared to the same period in 2006. This increase is partially offset primarily by a leveling off of our investment in standards-based products as they move closer to production. We currently anticipate increasing spending slightly on R&D during the second quarter of 2007 compared to spending in the first quarter of 2007.
Selling, General, and Administrative. Selling, general and administrative (“SG&A”) expenses consist primarily of salaries, commissions, bonuses and benefits for sales, marketing, executive and administrative personnel, as well as professional services and costs of other general corporate activities. SG&A expenses increased by $3.2 million or 39.3%, from $8.2 million for the three months ended March 31, 2006 to $11.4 million for the three months ended March 31, 2007. This increase is primarily due to the addition of our media server business, as well as an additional $677 thousand of stock-based compensation expense compared to the same period in 2006. We currently anticipate increasing spending slightly on SG&A during the second quarter of 2007 compared to spending in the first quarter of 2007.
Stock-based Compensation Expense. Stock-based compensation expense consists of amortization of stock-based compensation associated with stock options, unvested restricted shares and shares issued to employees as a result of the employee stock purchase plan (“ESPP”). Stock-based compensation expense increased by $935 thousand or 72.1%, from $1.3 million for the three months ended March 31, 2006 to $2.2 million for the three months ended March 31, 2007. The increase is primarily due to the diminishing benefit associated with the 2004 acceleration of employee stock options. We currently anticipate stock-based compensation expense to increase by approximately $300 thousand in the second quarter of 2007.

 

19


Table of Contents

We recognized stock-based compensation expense as follows (in thousands):
                 
    For the Three Months Ended  
    March 31,  
    2007     2006  
Cost of sales
  $ 262     $ 218  
Research and development
    602       388  
Selling, general and administrative
    1,367       690  
 
           
 
  $ 2,231     $ 1,296  
 
           
Deferred Compensation Expense. On September 1, 2006, all outstanding Convedia stock options vested and were considered exercised immediately. The proceeds of which were distributed as follows: 75% of the purchase price per share less the exercise price was paid to the option holder at closing and the remaining 25% will be paid in full to those Convedia employees still employed by RadiSys after one year of service. The 75% paid at the time of the acquisition is included in the purchase price and is allocated to goodwill. The remaining 25% is recorded as deferred compensation and amortized over the period of required service (one year). Pursuant to the purchase agreement, any forfeitures are reallocated to the remaining Convedia shareholders and option holders.
We recognized deferred compensation expense as follows (in thousands):
                 
    For the Three Months Ended  
    March 31,  
    2007     2006  
Cost of sales
  $ 25     $  
Research and development
    160        
Selling, general, and administrative
    282        
 
           
 
  $ 467     $  
 
           
Intangible Assets Amortization. Intangible assets consist of purchased technology, patents and other identifiable intangible assets. Intangible assets amortization expense was $4.3 million and $325 thousand for the three months ended March 31, 2007 and 2006, respectively. Intangible assets amortization increased due to intangible assets acquired with the purchase of Convedia. We perform reviews for impairment of the purchased intangible assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
Restructuring and Other Charges. We evaluate the adequacy of the accrued restructuring and other charges on a quarterly basis. As a result, we record certain reclassifications and reversals to the accrued restructuring and other charges based on the results of the evaluation. The total accrued restructuring and other charges for each restructuring event are not affected by reclassifications. Reversals are recorded in the period in which we determine that expected restructuring and other obligations are less than the amounts accrued. Tables summarizing the activity in the accrued liability for each restructuring event are contained in Note 7 of the notes to the unaudited consolidated financial statements.
First Quarter 2007 Restructuring
During the first quarter of 2007, we incurred employee-related expenses associated with certain engineering realignments. The costs incurred in this restructuring event are associated with employee termination benefits, including severance and medical benefits. All restructuring activities are expected to be completed by June 30, 2007. During the three months ended March 31, 2007, we incurred $127 thousand associated with employee termination expenses, including severance and medical benefits.
Fourth Quarter 2006 Restructuring
During the fourth quarter of 2006, we initiated a restructuring plan that included the elimination of 12 positions primarily supporting our contract manufacturing operations as a result of the termination of our relationships with one of our contract manufacturers in North America. The restructuring plan also includes closing our Charlotte office. During the three months ended March 31, 2007, we incurred additional severance and other employee-related separation costs of $61 thousand offset by reversals of $100 thousand associated with three employees that found new positions within the Company.

 

20


Table of Contents

Interest Expense. Interest expense includes interest incurred on the convertible senior and the convertible subordinated notes. Interest expense decreased $4 thousand, or 0.9%, from $436 thousand for the three months ended March 31, 2006 to $432 thousand for the three months ended March 31, 2007. The decrease in the interest expense for the three months ended March 31, 2007 compared to the same period in 2006 is due to the decrease in interest expense associated with the repurchase of $100 thousand in principal amount of the convertible subordinated notes in 2006.
Interest Income. Interest income decreased $607 thousand, or 27.1%, from $2.2 million for the three months ended March 31, 2006 to $1.6 million for the three months ended March 31, 2007. Interest income decreased as a result of a lower average balance of cash, cash equivalents and investments for the three months ended March 31, 2007 compared to the same period in 2006 due primarily to the purchase of Convedia. This decrease was offset by increasing interest rates and a shift in our investment portfolio towards higher yielding auction rate securities has also contributed to the increase in interest income.
Other Income (Expense), Net. Other income (expense), net, primarily includes foreign currency exchange gains and losses. Other expense, net, was $56 thousand for the three months ended March 31, 2007 compared to other income, net of $11 thousand for the three months ended March 31, 2006. Foreign currency exchange rate fluctuations resulted in a net loss of $15 thousand for the three months ended March 31, 2007 compared to a net gain of $11 thousand for the three months ended March 31, 2006.
Net of the change in net losses related to foreign currency exchange rate fluctuations, the change in Other expense, net, for the three months ended March 31, 2007 compared to the same period in 2006, is primarily attributable to a losses associated with the cash surrender value of the life insurance policies included in our executive deferred compensation plan.
Income Tax Provision (Benefit). We recorded a tax benefit of $780 thousand and a tax provision of $406 thousand for the three months ended March 31, 2007 and 2006, respectively. We expect the effective tax rate for the year ending December 31, 2007 to be between 11% and 16% compared to 5.4% for the year ended December 31, 2006. The increase in the effective tax rate between the 2007 and the year ended December 31, 2006 is primarily due to the impact of stock compensation, in-process R&D and intangible amortization related to the Convedia acquisition, and taxes on foreign income that differ from U.S. tax rate.
On December 20, 2006, President Bush signed the Tax Relief and Health Care Act of 2006 (the “Tax Relief Act”), which extended the research and development tax credit. Under the Tax Relief Act, the research and development tax credit was retroactively reinstated to January 1, 2006 and is available through December 31, 2007. We expect to record a federal research and development credit of approximately $550 thousand for the year ending 2007.
The 2007 estimated effective tax rate is based on current tax law and the current expected income and assumes that we continue to receive the tax benefits associated with certain income associated with foreign jurisdictions. The tax rate may be affected by potential acquisitions, restructuring events or divestitures, the jurisdictions in which profits are determined to be earned and taxed and the ability to realize deferred tax assets.
Liquidity and Capital Resources
The following table summarizes selected financial information as of the dates indicated and for each of the three months ended on the dates indicated:
                         
    March 31,     December 31,     March 31,  
    2007     2006     2006  
    (Dollar amounts in thousands)  
Cash and cash equivalents
  $ 26,631     $ 23,734     $ 91,802  
Short-term investments
  $ 89,150     $ 102,250     $ 139,400  
Long-term investments
  $ 10,000     $ 10,000     $  
 
                 
Cash and cash equivalents and investments
  $ 125,781     $ 135,984     $ 231,202  
 
                 
Working capital
  $ 165,413     $ 161,575     $ 256,920  
Accounts receivable, net
  $ 49,840     $ 42,549     $ 44,586  
Inventories, net
  $ 33,752     $ 35,184     $ 13,243  
Accounts payable
  $ 34,425     $ 36,699     $ 35,127  
Convertible senior notes
  $ 97,446     $ 97,412     $ 97,312  
Convertible subordinated notes
  $ 2,413     $ 2,410     $ 2,501  
Days sales outstanding (A)
    68       53       62  
Days to pay (B)
    66       68       67  
Inventory turns (C)
    5.6       7.5       14.4  
Inventory turns — days (D)
    65       73       25  
Cash cycle time — days (E)
    67       58       20  

 

21


Table of Contents

 
(A)  
Based on ending net trade receivables divided by daily revenue (quarterly revenue, annualized and divided by 365 days).
 
(B)  
Based on ending accounts payable divided by daily cost of sales (quarterly cost of sales, annualized and divided by 365 days).
 
(C)  
Based on quarterly cost of sales, annualized divided by ending inventory.
 
(D)  
Based on ending inventory divided by quarterly cost of sales (annualized and divided by 365 days).
 
(E)  
Days sales outstanding plus inventory turns — days, less days to pay.
Cash and cash equivalents increased by $2.9 million from $23.7 million at December 31, 2006 to $26.6 million at March 31, 2007. Activities impacting cash and cash equivalents are as follows:
Cash Flows
                 
    For the Three Months Ended  
    March 31,  
    2007     2006  
    (In thousands)  
Cash provided by (used in) operating activities
  $ (10,383 )   $ 4,222  
Cash provided by (used in) investing activities
    11,936       (4,882 )
Cash provided by financing activities
    1,307       2,326  
Effects of exchange rate changes
    37       81  
 
           
Net increase in cash and cash equivalents
  $ 2,897     $ 1,747  
 
           
During the three months ended March 31, 2007 and 2006, we used $1.1 million and $1.3 million, respectively, for capital expenditures. During the three months ended March 31, 2007, capital expenditures were primarily associated with integrating the media server business, upgrading our internal infrastructure as well as increasing manufacturing capabilities in our Hillsboro facility. During the three months ended March 31, 2006, capital expenditures were primarily associated with our increased investment in the development and marketing of our standards-based solutions.
During the three months ended March 31, 2007 and 2006, we received $1.3 million and $2.3 million, respectively, in proceeds from the issuance of common stock through our stock compensation plans.
During the third quarter of 2006, we announced our decision to disengage from one of our contract manufacturers in North America. We have transitioned the majority of this production to our Hillsboro facility. This has resulted in a net increase in inventory related to this transition and we expect inventory to continue to decrease throughout the year as we consume and sell the inventory related to transitions and changes in our production strategy. Also, due to the inherent risks associated with this transfer of production we may incur additional expenses related to adverse purchase commitments or excess and obsolete inventory. We may incur additional and unanticipated expenses or delays which may have a material adverse effect on our business or our financial performance. Our manufacturing strategy is to outsource our higher volume products.
Changes in foreign currency rates impacted beginning cash balances during the three months ended March 31, 2007 by $37 thousand. Due to our international operations where transactions are recorded in functional currencies other than the U.S. Dollar, the effects of changes in foreign currency exchange rates on existing cash balances during any given periods results in amounts on the consolidated statements of cash flows that may not reflect the changes in the corresponding accounts on the consolidated balance sheets.
As of March 31, 2007 and December 31, 2006 working capital was $165.4 million and $161.6 million, respectively. Working capital increased by $3.8 million due to primarily to the positive cash flow from investing and financing activities generated during the three months ended March 31, 2007.

 

22


Table of Contents

Management believes that cash flows from operations, available cash balances and short-term borrowings will be sufficient to fund our operating liquidity needs for the short-term and long-term future.
Investments
Investments consisted of the following (in thousands):
                 
    March 31,     December 31,  
    2007     2006  
Short-term investments, classified as available-for-sale
  $ 89,150     $ 102,250  
 
           
Long-term held-to-maturity investments
  $ 10,000     $ 10,000  
 
           
We invest excess cash in debt instruments of the U.S. Government and its agencies, high-quality corporate issuers and municipalities. As of March 31, 2007, we had $89.2 million investments classified as available-for-sale. As of March 31, 2007, we had $10.0 million long-term held-to-maturity investments. During 2006, we shifted our investments to auction rate securities as we were actively evaluating potential acquisitions and partnership opportunities. Our investment policy requires that the total investment portfolio, including cash and investments, not exceed a maximum weighted-average maturity of 18 months. In addition, the policy mandates that an individual investment must have a maturity of less than 36 months, with no more than 20% of the total portfolio exceeding 24 months. As of March 31, 2007, we were in compliance with our investment policy.
Line of Credit
During the quarter ended March 31, 2006, we transferred our $20.0 million line of credit facility from our commercial bank to an investment bank. This line of credit facility has an interest rate based on the 30-day London Inter-Bank Offered Rate (“LIBOR”) plus 0.75%. The line of credit is collateralized by our non-equity investments. At March 31, 2007, we had a standby letter of credit outstanding related to one of our medical insurance carriers for $105 thousand. The market value of non-equity investments must exceed 125% of the borrowed facility amount, and the investments must meet specified investment grade ratings.
As of March 31, 2007 and December 31, 2006, there were no outstanding balances on the standby letter of credit or line of credit and we were in compliance with all debt covenants.
Convertible Senior Notes
During November 2003, we completed a private offering of $100 million in aggregate principal amount of 1.375% convertible senior notes due November 15, 2023 to qualified institutional buyers. The discount at issuance on the convertible senior notes amounted to $3 million.
The convertible senior notes are unsecured obligations convertible into our common stock and rank equally in right of payment with all existing and future obligations that are unsecured and unsubordinated. Interest on the convertible senior notes accrues at 1.375% per year and is payable semi-annually on May 15 and November 15. The notes are convertible, at the option of the holder, at any time on or prior to maturity under certain circumstances unless previously redeemed or repurchased, into shares of our common stock at a conversion price of $23.57 per share, which is equal to a conversion rate of 42.4247 shares per $1,000 principal amount of notes. The notes are convertible if (i) the closing price of our common stock on the trading day prior to the conversion date reaches 120% or more of the conversion price of the notes on such trading date, (ii) the trading price of the notes falls below 98% of the conversion value or (iii) certain other events occur. Upon conversion, we will have the right to deliver, in lieu of common stock, cash or a combination of cash and common stock. We may redeem all or a portion of the notes at our option on or after November 15, 2006 but before November 15, 2008 provided that the closing price of our common stock exceeds 130% of the conversion price for at least 20 trading days within a period of 30 consecutive trading days ending on the trading day before the date of the notice of the provisional redemption. On or after November 15, 2008, we may redeem the notes at any time. On November 15, 2008, November 15, 2013, and November 15, 2018, holders of the convertible senior notes will have the right to require us to purchase, in cash, all or any part of the notes held by such holder at a purchase price equal to 100% of the principal amount of the notes being purchased, together with accrued and unpaid interest and additional interest, if any, up to but excluding the purchase date. The accretion of the discount on the notes is calculated using the effective interest method.

 

23


Table of Contents

As of March 31, 2007 and December 31, 2006, we had outstanding convertible senior notes with a face value of $100 million and a book value of $97.4 million, net of unamortized discount of $2.6 million. The estimated fair value of the convertible senior notes was $96.6 million at March 31, 2007 and December 31, 2006.
Convertible Subordinated Notes
During August 2000, we completed a private offering of $120 million in aggregate principal amount of 5.5% convertible subordinated notes due August 15, 2007 to qualified institutional buyers. From 2000 to 2006, we repurchased $117.7 million in aggregate principal amount of the convertible subordinated notes, with an associated unamortized discount of $2.4 million. We repurchased the notes for $106.7 million and, as a result, recorded a gain of $8.5 million. As of March 31, 2007 and December 31, 2006, we had outstanding convertible subordinated notes with a face value of $2.4 million.
Contractual Obligations
The following summarizes our contractual obligations at March 31, 2007 and the effect of such on its liquidity and cash flows in future periods (in thousands).
                                                 
    2007*     2008     2009     2010     2011     Thereafter  
Future minimum lease payments
  $ 2,792     $ 3,600     $ 3,047     $ 2,718     $ 1,631     $  
Purchase obligations(A)
    26,486                                
Celestica Charlotte obligations
    320                                
Interest on convertible notes
    1,441       1,375       1,375       1,375       1,375       16,500  
Convertible senior notes(B)
          100,000                          
Convertible subordinated notes(B).
    2,418                                
 
                                   
Total
  $ 33,457     $ 104,975     $ 4,422     $ 4,093     $ 3,006     $ 16,500  
 
                                   
 
*  
Remaining nine months
 
(A)  
Purchase obligations include agreements or purchase orders to purchase goods or services that are enforceable and legally binding and specify all significant terms, including: fixed or minimum quantities to be purchased; fixed, minimum or variable price provisions and the approximate timing of the transaction. Purchase obligations exclude agreements that are cancelable without penalty.
 
(B)  
The convertible senior notes and the convertible subordinated notes are shown at their face values, gross of unamortized discount amounting to $2.6 million and $8 thousand, respectively, at December 31, 2006. On or after November 15, 2008, we may redeem the convertible senior notes at any time. On November 15, 2008, November 15, 2013, and November 15, 2018, holders of the convertible senior notes will have the right to require us to purchase, in cash, all or any part of the notes held by such holder at a purchase price equal to 100% of the principal amount of the notes being purchased, together with accrued and unpaid interest and additional interest, if any, up to but excluding the purchase date. The convertible subordinated notes are payable in full in August 2007.
In addition to the above, as discussed in Note 11 to our consolidated financial statements, we have approximately $2.0 million associated with unrecognized tax benefits and related interest and penalties. These liabilities are primarily included as a component of “other long-term liabilities” in our consolidated balance sheet as we do not anticipate that settlement of the liabilities will require payment of cash within the next twelve months. We are not able to reasonably estimate when we would make any cash payments required to settle these liabilities, but do not believe that the ultimate settlement of our obligations will materially affect our liquidity.
Off-Balance Sheet Arrangements
We do not engage in any activity involving special purpose entities or off-balance sheet financing.
Liquidity Outlook
We believe that our current cash and cash equivalents and investments, net, amounting to $125.8 million at March 31, 2007 and the cash generated from operations will satisfy our short and long-term expected working capital needs, capital expenditures, and other liquidity requirements associated with our existing business operations. Capital expenditures are expected to range from $1.5 million to $2.0 million per quarter as we make additional R&D and IT capital investments. We plan to actively continue evaluating potential acquisitions and partnership opportunities which could affect our liquidity.

 

24


Table of Contents

FORWARD-LOOKING STATEMENTS
This Quarterly Report contains forward-looking statements. Some of the forward-looking statements contained in this Quarterly Report include:
   
our statements concerning our beliefs about the success of our shift in business strategy from perfect fit solutions to standards-based solutions;
 
   
the adoption by our customers of standards-based solutions and ATCA;
 
   
the size of the addressable market for ATCA;
 
   
estimates of anticipated revenue from design wins;
 
   
expectations and goals for revenues, gross margin, R&D expenses, selling, general, administrative expenses and profits;
 
   
estimates and impact of stock-based compensation expense;
 
   
expectations about the benefits from and integration of the operations, technologies, products or personnel from the acquisition of Convedia;
 
   
estimates and impact of the costs of the acquisition of Convedia;
 
   
statements concerning certain strategic partnerships;
 
   
the impact of our restructuring events on future revenues;
 
   
currency exchange rate fluctuations, changes in tariff and trade policies and other risks associated with foreign operations;
 
   
our projected liquidity; and
 
   
matters affecting the computer manufacturing industry including changes in industry standards, changes in customer requirements and new product introductions, as well as other risks described in “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2006 and as updated in this Quarterly Report.
All statements that relate to future events or to our future performance are forward-looking statements. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “expect,” “plans,” “seeks,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “seek to continue,” “intends,” or other comparable terminology. These forward-looking statements are made pursuant to safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results or our industries’ actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements.
Forward-looking statements in this Quarterly Report on Form 10-Q include discussions of our goals, including those discussions set forth in Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” We cannot provide assurance that these goals will be achieved.
Although forward-looking statements help provide additional information about us, investors should keep in mind that forward-looking statements are only predictions, at a point in time, and are inherently less reliable than historical information. In evaluating these statements, you should specifically consider the risks outlined above and those listed under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2006 and as updated in our quarterly reports on Form 10-Q. These risk factors may cause our actual results to differ materially from any forward-looking statement.

 

25


Table of Contents

We do not guarantee future results, levels of activity, performance or achievements and we do not assume responsibility for the accuracy and completeness of these statements. The forward-looking statements contained in this Quarterly Report on Form 10-Q are made and based on information as of the date of this report. We assume no obligation to update any of these statements based on information after the date of this report.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
We are exposed to market risk from changes in interest rates, foreign currency exchange rates, and equity trading prices, which could affect our financial position and results of operations.
Interest Rate Risk. We invest excess cash in debt instruments of the U.S. Government and its agencies, high-quality corporate issuers and municipalities. We attempt to protect and preserve our invested funds by limiting default, market, and reinvestment risk. Investments in both fixed rate and floating rate interest earning instruments carry a degree of interest rate risk. Fixed rate securities may have their fair value adversely affected due to a rise in interest rates while floating rate securities may produce less income than expected if interest rates decline. Due to the short duration of most of the investment portfolio, an immediate 10% change in interest rates would not have a material effect on the fair value of our investment portfolio. Additionally, the interest rate changes affect the fair market value but do not necessarily have a direct impact on our earnings or cash flows. Therefore, we would not expect our operating results or cash flows to be affected, to any significant degree, by the effect of a sudden change in market interest rates on the securities portfolio. The estimated fair value of our debt securities that we have invested in at March 31, 2007 and December 31, 2006 was $99.2 million and $112.5 million, respectively. The effect of an immediate 10% change in interest rates would not have a material effect on our operating results or cash flows.
Foreign Currency Risk. We pay the expenses of our international operations in local currencies, namely, the Euro, British Pound Sterling, New Shekel, Japanese Yen, Chinese Renminbi and Canadian Dollar. The international operations are subject to risks typical of an international business, including, but not limited to: differing economic conditions, changes in political climate, differing tax structures, foreign exchange rate volatility and other regulations and restrictions. Accordingly, future results could be materially and adversely affected by changes in these or other factors. We are also exposed to foreign exchange rate fluctuations as the balance sheets and income statements of our foreign subsidiaries are translated into U.S. Dollars during the consolidation process. Because exchange rates vary, these results, when translated, may vary from expectations and adversely affect overall expected profitability. Foreign currency exchange rate fluctuations resulted in a net loss of $15 thousand and a net gain of $11 thousand for the three months ended March 31, 2007 and 2006, respectively.
Convertible Notes. The fair values of the convertible senior and convertible subordinated notes are sensitive to interest rate changes. Interest rate changes would result in increases or decreases in the fair value of the convertible notes, due to differences between market interest rates and rates in effect at the inception of the obligation. Unless we elect to repurchase our convertible notes in the open market, changes in the fair value of convertible notes have no impact on our cash flows or consolidated financial statements. The estimated fair value of the convertible senior notes was $96.6 million at March 31, 2007 and December 31, 2006 and the estimated fair value of the convertible subordinated notes was $2.4 million at March 31, 2007 and December 31, 2006.
Item 4. Controls and Procedures
Based on their evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective.
In connection with the evaluation described above, we identified no change in our internal control over financial reporting that occurred during the three months ended March 31, 2007, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
Management excluded from its assessment of the effectiveness of the Company’s disclosure controls and procedures and internal control over financial reporting, the disclosure controls and procedures and internal controls of Convedia, which was acquired effective September 1, 2006. Management was unable to assess the effectiveness of the disclosure controls and procedures and internal control over financial reporting of Convedia because of the timing of the acquisition. Management expects to update its assessment of the effectiveness of the disclosure controls and procedures and internal control over financial reporting to include Convedia as soon as practicable, but in any event, no later than in the Form 10-Q for the quarterly period ended September 30, 2007.

 

26


Table of Contents

PART II. OTHER INFORMATION
Item 1A. Risk Factors
There are many factors that affect our business and the results of our operations, many of which are beyond our control. In addition to the other information set forth in this quarterly report, you should carefully consider the factors discussed in Part I, Item 1A. Risk Factors and Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2006, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K for the year ended December 31, 2006, as updated in this Quarterly Report, are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.
We may need to raise additional capital in the future to repay our convertible senior notes, and existing or future resources may not be available to us in sufficient amounts or on acceptable terms.
During November 2003, we completed a private offering of $100 million in aggregate principal amount of convertible senior notes due November 15, 2023 to qualified institutional buyers. The notes are convertible prior to maturity into shares of our common stock at a conversion price of $23.57 per share under certain circumstances that include but are not limited to (i) conversion due to the closing price of our common stock on the trading day prior to the conversion date reaching 120% or more of the conversion price of the notes on such trading date and (ii) conversion due to the trading price of the notes falling below 98% of the conversion value. Upon conversion we will have the right to deliver, in lieu of common stock, cash or a combination of cash and common stock. We may redeem all or a portion of the notes at our option on or after November 15, 2006 but before November 15, 2008 provided that the closing price of our common stock exceeds 130% of the conversion price for at least 20 trading days within a period of 30 consecutive trading days ending on the trading day before the date of the notice of the provisional redemption. As of March 31, 2007, the convertible senior notes were not redeemable at our option. On or after November 15, 2008, we may redeem the notes at any time. On November 15, 2008, November 15, 2013, and November 15, 2018, holders of the convertible senior notes will have the right to require us to purchase, in cash, all or any part of the notes held by such holder at a purchase price equal to 100% of the principal amount of the notes being purchased, together with accrued and unpaid interest and additional interest, if any, up to but excluding the purchase date.
As of March 31, 2007, we had outstanding convertible senior notes with a face value of $100 million. While we cannot predict whether or when holders of the convertible senior notes will choose to exercise their repurchase rights, we believe that they would become more likely to do so in the event that the price of our common stock is not greater than certain levels or if interest rates increase, or both. Therefore, if a substantial portion of the convertible senior notes were to be submitted for repurchase on any of the repurchase dates, we might need to use a substantial amount of our available sources of liquidity for this purpose. Consequently, such repurchase could have the effect of restricting our ability to fund new acquisitions or to meet other future working capital needs, as well as increasing our costs of borrowing. We may seek other means of refinancing or restructuring our obligations under the convertible senior notes, but this may result in terms less favorable than those under the existing convertible senior notes.
Other Risk Factors Related to Our Business
Other risk factors include, but are not limited to, changes in the mix of products sold, changes in regulatory and tax legislation, changes in effective tax rates, inventory risks due to changes in market demand or our business strategies, potential litigation and claims arising in the normal course of business, credit risk of customers and other risk factors. Additionally, proposed changes to accounting rules could materially affect what we report under GAAP and adversely affect our operating results.
Item 6. Exhibits
(a) Exhibits
     
Exhibit No   Description
3.1
  Restated Bylaws.
 
   
31.1
  Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
   
31.2
  Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
   
32.1
  Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
   
32.2
  Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

27


Table of Contents

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
  RADISYS CORPORATION
 
 
Dated: May 8, 2007  By:   /s/ SCOTT C. GROUT    
    Scott C. Grout   
    President and Chief Executive Officer   
 
     
Dated: May 8, 2007  By:   /s/ BRIAN J. BRONSON    
    Brian J. Bronson   
    Chief Financial Officer   
 

 

28


Table of Contents

EXHIBIT INDEX
     
Exhibit No   Description
3.1
  Restated Bylaws.
 
   
31.1
  Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
   
31.2
  Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
   
32.1
  Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
   
32.2
  Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

29

EX-3.1 2 c70473exv3w1.htm EXHIBIT 3.1 exv3w1
 

Exhibit 3.1

AMENDED AND RESTATED BYLAWS

OF

RADISYS CORPORATION

ARTICLE I

SHAREHOLDERS MEETINGS AND VOTING

1.1 ANNUAL MEETING. The annual meeting of the shareholders shall be held on the third Tuesday in May of each year at 10:00 a.m., unless a different date or time is fixed by the Board of Directors and stated in the notice of the meeting. Failure to hold an annual meeting on the stated date shall not affect the validity of any corporate action.

1.2 SPECIAL MEETINGS. Special meetings of the shareholders, for any purposes, unless otherwise prescribed by statute, may be called by the Chairman of the Board or the Board of Directors and shall be called by the Chairman of the Board upon the written demand of the holders of not less than one-tenth of all the votes entitled to be cast on any issue proposed to be considered at the meeting. The demand shall describe the purposes for which the meeting is to be held and shall be signed, dated and delivered to the Secretary.

1.3 PLACE OF MEETINGS. Meetings of the shareholders shall be held at any place in or out of Oregon designated by the Board of Directors. If a meeting place is not designated by the Board of Directors, the meeting shall be held at the Corporation’s principal office.

1.4 NOTICE OF MEETINGS. Written or printed notice stating the date, time and place of the shareholders meeting and, in the case of a special meeting or a meeting for which special notice is required by law, the purposes for which the meeting is called, shall be delivered by the Corporation to each shareholder entitled to vote at the meeting and, if required by law, to any other shareholders entitled to receive notice, not earlier than 60 days nor less than 10 days before the meeting date. If mailed, the notice shall be deemed delivered when it is mailed to the shareholder with postage prepaid at the shareholder’s address shown in the Corporation’s record of shareholders.

1.5 WAIVER OF NOTICE. A shareholder may at any time waive any notice required by law, these Bylaws or the Articles of Incorporation. The waiver shall be in writing, be signed by the shareholder entitled to the notice and be delivered to the Corporation for inclusion in the minutes for filing with the corporate records. A shareholder’s attendance at a meeting waives objection to (i) lack of notice or defective notice of the meeting, unless the shareholder at the beginning of the meeting objects to holding the meeting or transacting business at the meeting, and (ii) consideration of a particular matter at the meeting that is not within the purposes described in the meeting notice, unless the shareholder objects to considering the matter when it is presented.

1

 

 

1


 

1.6 FIXING OF RECORD DATE. The Board of Directors may fix a future date, or a later time on the date the board fixes the record date, as the record date to determine the share holders entitled to notice of a shareholders meeting, demand a special meeting, vote, take any other action or receive payment of any share or cash dividend or other distribution. This date shall not be earlier than 70 days before the meeting or action requiring a determination of shareholders. The record date for any meeting, vote or other action of the shareholders shall be the same for all voting groups. If not otherwise fixed by the Board of Directors, the record date to determine shareholders entitled to notice of and to vote at an annual or special shareholders meeting is the close of business on the day before the notice is first mailed or otherwise transmitted to shareholders. If not otherwise fixed by the Board of Directors, the record date to determine shareholders entitled to receive payment of any share or cash dividend or other distribution is the close of business on the day the Board of Directors authorizes the share or cash dividend or other distribution.

1.7 SHAREHOLDERS LIST FOR MEETING. After a record date for a meeting is fixed, the Corporation shall prepare an alphabetical list of all shareholders entitled to notice of the shareholders meeting. The list shall be arranged by voting group and, within each voting group, by class or series of shares, and it shall show the address of and number of shares held by each shareholder. The shareholders list shall be available for inspection by any shareholder, upon proper demand as may be required by law, beginning two business days after notice of the meeting is given and continuing through the meeting, at the Corporation’s principal office or at a place identified in the meeting notice in the city where the meeting will be held. The Corporation shall make the shareholders list available at the meeting, and any shareholder or the shareholder’s agent or attorney shall be entitled to inspect the list at any time during the meeting or any adjournment. Refusal or failure to prepare or make available the shareholders list does not affect the validity of action taken at the meeting.

1.8 QUORUM; ADJOURNMENT.

(1) Shares entitled to vote as a separate voting group may take action on a matter at a meeting only if a quorum of those shares exists with respect to that matter. A majority of the votes entitled to be cast on the matter by the voting group constitutes a quorum of that voting group for action on that matter.

(2) A majority of votes represented at the meeting, although less than a quorum, may adjourn the meeting from time to time to a different time and place without further notice to any shareholder of any adjournment, except that notice is required if a new record date is or must be set for the adjourned meeting. At an adjourned meeting at which a quorum is present, any business may be transacted that might have been transacted at the meeting originally held.

(3) Once a share is represented for any purpose at a meeting, it shall be present for quorum purposes for the remainder of the meeting and for any adjournment of that meeting unless a new record date is or must be set for the adjourned meeting. A new record date must be set if the meeting is adjourned to a date more than 120 days after the date fixed for the original meeting.

1.9 VOTING REQUIREMENTS; ACTION WITHOUT MEETING.

(1) If a quorum exists, action on a matter, other than the election of directors, by a voting group is approved if the votes cast within the voting group favoring the action exceed the votes cast opposing the action, unless a greater number of affirmative votes is required by law or the Articles of Incorporation. Unless otherwise provided in the Articles of Incorporation, directors are elected by a plurality of the votes cast by the shares entitled to vote in the election at a meeting at which a quorum is present.

2

 

 

2


 

(2) Action required or permitted by law to be taken at a shareholders meeting may be taken without a meeting if the action is taken by all the shareholders entitled to vote on the action. The action must be evidenced by one or more written consents describing the action taken, signed by all the shareholders entitled to vote on the action and delivered to the Secretary for inclusion in the minutes for filing with the corporate records.

Shareholder action taken by written consent is effective when the last shareholder signs the consent, unless the consent specifies an earlier or later effective date.

1.10 PROXIES. A shareholder may vote shares in person or by proxy. A shareholder may appoint a proxy by signing an appointment form either personally or by the shareholder’s attorney-in-fact. An appointment of a proxy is effective when received by the Secretary or other officer of the Corporation authorized to tabulate votes. An appointment is valid for 11 months unless a different period is provided in the appointment form. An appointment is revocable by the shareholder unless the appointment form conspicuously states that it is irrevocable and the appointment is coupled with an interest that has not been extinguished.

1.11 MEETING BY TELEPHONE CONFERENCE. Shareholders may participate in an annual or special meeting by, or conduct the meeting through, use of any means of communications by which all shareholders participating may simultaneously hear each other during the meeting, except that no meeting for which a written notice is sent to shareholders may be conducted by this means unless the notice states that participation in this manner is permitted and describes how any shareholder desiring to participate in this manner may notify the Corporation. Participation in a meeting by this means shall constitute presence in person at the meeting.

1.12 PROPER BUSINESS FOR SHAREHOLDERS’ MEETING. To be properly brought before the meeting, business must be either (i) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board of Directors, (ii) otherwise properly brought before a meeting by or at the direction of the Board of Directors, or (iii) otherwise properly brought before the meeting by a shareholder. In addition to any other applicable requirements, for business to be properly brought before an annual meeting by a shareholder, the shareholder must have given timely notice thereof in writing to the Secretary of the Corporation. To be timely, a shareholder’s notice must be delivered to or mailed and received at the principal executive office of the Corporation not less than 50 days nor more than 75 days prior to the meeting;

PROVIDED, HOWEVER, that in the event that less than 65 days’ notice or prior public disclosure of the date of the meeting is given or made to shareholders, notice by the shareholder to be timely must be so received not later than the close of business on the 10th day following the day on which such notice of the date of the meeting was mailed or such public disclosure was made, whichever first occurs. A shareholder’s notice to the Secretary shall set forth (i) one or more matters appropriate for shareholder action that the shareholder proposes to bring before the meeting, (ii) a brief description of the matters desired to be brought before the meeting and the reasons for conducting such business at the meeting, (iii) the name and record address of the shareholder, (iv) the class and number of shares of the Corporation that the shareholder owns or is entitled to vote and (v) any material interest of the shareholder in such matters.

3

 

 

3


 

Notwithstanding anything in these bylaws to the contrary, no business shall be conducted at the annual meeting except in accordance with the procedure set forth in this Section 1.12; PROVIDED, HOWEVER, that nothing in this Section 1.12 shall be deemed to preclude discussion by any shareholder of any business properly brought before the meeting. The Chairman of the Board, or the President in the absence of the Chairman of the Board, shall, if the facts warrant, determine and declare to the meeting that the business was not properly brought before the meeting in accordance with the provisions of this Section 1.12 and if the Chairman of the Board, or the President in the absence of the Chairman of the Board, should so determine, shall so declare to the meeting any such business not properly brought before the meeting shall not be transacted.

1.13 SHAREHOLDER NOMINATION OF DIRECTORS.

(1) Not less than 50 days nor more than 75 days prior to the date of any annual meeting of shareholders, any shareholder who intends to make a nomination at the annual meeting shall deliver a notice to the Secretary of the Corporation setting forth (i) as to each nominee whom the shareholder proposes to nominate for election or reelection as a director, (a) the name, age, business address and residence address of the nominee, (b) the principal occupation or employment of the nominee, (c) the class and number of shares of capital stock of the Corporation that are beneficially owned by the nominee of shares of capital stock of the Corporation that are beneficially owned by the nominee and (d) any other information concerning the nominee that would be required, under the rules of the Securities and Exchange Commission, in a proxy statement soliciting proxies for the election of such nominee; and (ii) as to the shareholder giving the notice, (a) the name and record address of the shareholder and (b) the class and number of shares of capital stock of the Corporation that are beneficially owned by the shareholder; PROVIDED, HOWEVER, that in the event that less than 65 days’ notice or prior public disclosure of the date of the annual meeting is given or made to shareholders, notice by the shareholder to be timely must be so delivered not later than the close of business on the 10th day following the day on which such notice of the date of the meeting was mailed or such public disclosure was made, whichever first occurs. Such notice shall include a signed consent to serve as a director of the Corporation, if elected, of each such nominee. The Corporation may require any proposed nominee to furnish such other information as may reasonably be required by the Corporation to determine the eligibility of such proposed nominee to serve as a director of the corporation.

(2) Any shareholder who intends to make a nomination at any special meeting of shareholders held for the purpose of electing directors shall deliver a timely notice to the Secretary of the Corporation setting forth (i) as to each nominee whom the shareholder proposes to nominate for election or reelection as a director, (a) the name, age, business address and residence address of the nominee, (b) the principal occupation or employment of the nominee, (c) the class and number of shares of capital stock of the corporation that are beneficially owned by the nominee of shares of capital stock of the corporation that are beneficially owned by the nominee and (d) any other information concerning the nominee that would be required, under the rules of the Securities and Exchange Commission, in a proxy statement soliciting proxies for the election of such nominee; and (ii) as to the shareholder giving the notice, (a) the name and record address of the shareholder and (b) the class and number of shares of capital stock of the Corporation that are beneficially owned by the shareholder. To be timely for these purposes, such notice must be given (i) if given by the shareholder (or any of the shareholders) who or that made a demand for a meeting pursuant to which such meting is to be held, concurrently with the delivery of such demand, and (ii) otherwise, not later than the close of business on the 10th day following the date on which the notice of the special meeting was mailed. Such notice shall include a signed consent to serve as a director of the Corporation, if elected, of each such nominee. The Corporation may require any proposed nominee to furnish such other information as may reasonably be required by the Corporation to determine the eligibility of such proposed nominee to serve as a director of the Corporation.

4

 

 

4


 

(3) The Chairman of the Board, or the President in the absence of the Chairman of the Board, shall, if the facts warrant, determine and declare that a nominee was not properly nominated in accordance with the provisions of this Section 1.13 and if the Chairman of the Board, or the President in the absence of the Chairman of the Board, should so determine, shall so declare to the meeting any such nominee shall not be considered by shareholders.

ARTICLE II

BOARD OF DIRECTORS

2.1 DUTIES OF BOARD OF DIRECTORS. All corporate powers of the Corporation shall be exercised by or under the authority of its Board of Directors; the business and affairs of the Corporation shall be managed under the direction of its Board of Directors.

2.2 NUMBER, TERM AND QUALIFICATION. The number of directors of the Corporation shall be at least one and no more than ten. Within this range, at the time of adoption of these Restated Bylaws the number of directors shall be six, and the number of directors shall otherwise be determined from time to time by the Board of Directors. The term of a director shall expire at the next annual meeting of shareholders after his or her election. Despite the expiration of a director’s term, the director shall continue to serve until the director’s successor is elected and qualified or the number of directors is decreased.

Directors need not be residents of the State of Oregon or shareholders of the Corporation.

2.3 REGULAR MEETINGS. A regular meeting of the Board of Directors may be held without notice other than this Bylaw immediately after, and at the same place as, the annual meeting of shareholders. The Board of Directors may provide by resolution the time and place for the holding of additional regular meetings in or out of Oregon without notice other than the resolution.

2.4 SPECIAL MEETINGS. Special meetings of the Board of Directors may be called by or at the request of the Chief Executive Officer or any two directors. The person or persons authorized to call special meetings of the Board of Directors may fix any place in or out of Oregon as the place for holding any special meeting of the Board of Directors called by them.

2.5 NOTICE. Notice of the date, time and place of any special meeting of the Board of Directors shall be given at least 24 hours prior to the meeting by notice communicated in person, by telephone, telegraph, teletype, other form of wire or wireless communication, mail or private carrier. If written, notice shall be effective at the earliest of (a) when received, (b) three days after its deposit in the United States mail, as evidenced by the postmark, if mailed postpaid and correctly addressed, or (c) on the date shown on the return receipt, if sent by registered or certified mail, return receipt requested and the receipt is signed by or on behalf of the addressee. Notice by all other means shall be deemed effective when received by or on behalf of the director.

Notice of any regular or special meeting need not describe the purposes of the meeting unless required by law or the Articles of Incorporation.

5

 

 

5


 

2.6 WAIVER OF NOTICE. A director may at any time waive any notice required by law, these Bylaws or the Articles of Incorporation. Except as set forth below, the waiver must be in writing, be signed by the director entitled to the notice, specify the meeting for which notice is waived and be filed with the minutes or corporate records. A director’s attendance at or participation in a meeting waives any required notice to the director of the meeting unless the director at the beginning of the meeting, or promptly upon the director’s arrival, objects to holding the meeting or transacting business at the meeting and does not thereafter vote for or assent to action taken at the meeting.

2.7 QUORUM. A majority of the number of directors set forth in Section 2.2 of these Bylaws shall constitute a quorum for the transaction of business at any meeting of the Board of Directors. If less than a quorum is present at a meeting, a majority of the directors present may adjourn the meeting from time to time without further notice.

2.8 MANNER OF ACTING. The act of the majority of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors, unless a different number is provided by law, the Articles of Incorporation or these Bylaws.

2.9 MEETING BY TELEPHONE CONFERENCE; ACTION WITHOUT MEETING.

(1) Directors may participate in a regular or special meeting by, or conduct the meeting through, use of any means of communications by which all directors participating may simultaneously hear each other during the meeting. Participation in a meeting by this means shall constitute presence in person at the meeting.

(2) Any action that is required or permitted to be taken at a meeting of the Board of Directors may be taken without a meeting if one or more written consents describing the action taken are signed by all of the directors entitled to vote on the matter and included in the minutes or filed with the corporate records reflecting the action taken. The action shall be effective when the last director signs the consent, unless the consent specifies an earlier or later effective date.

2.10 VACANCIES. Any vacancy on the Board of Directors, including a vacancy resulting from an increase in the number of directors, may be filled by the shareholders, the Board of Directors, the remaining directors if less than a quorum (by the vote of a majority thereof) or by a sole remaining director. Any vacancy not filled by the directors shall be filled by election at an annual meeting or at a special meeting of shareholders called for that purpose. A vacancy that will occur at a specified later date, by reason of a resignation or otherwise, may be filled before the vacancy occurs, but the new director may not take office until the vacancy occurs.

2.11 COMPENSATION. By resolution of the Board of Directors, the directors may be paid reasonable compensation for services as directors and their expenses of attending meetings of the Board of Directors.

2.12 PRESUMPTION OF ASSENT. A director who is present at a meeting of the Board of Directors or a committee of the Board of Directors shall be deemed to have assented to the action taken at the meeting unless (a) the director’s dissent or abstention from the action is entered in the minutes of the meeting, (b) the director delivers a written notice of dissent or abstention to the action to the presiding officer of the meeting before any adjournment or to the Corporation immediately after the adjournment of the meeting or (c) the director objects at the beginning of the meeting or promptly upon the director’s arrival to the holding of the meeting or transacting business at the meeting. The right to dissent or abstain is not available to a director who voted in favor of the action.

6

 

 

6


 

2.13 RESIGNATION. Any director may resign by delivering written notice to the Board of Directors, its chairperson or the Corporation. Unless the notice specifies a later effective date, a resignation notice shall be effective upon the earlier of (a) receipt, (b) five days after its deposit in the United States mails, if mailed postpaid and correctly addressed, or (c) on the date shown on the return receipt, if sent by registered or certified mail, return receipt requested, and the receipt is signed by addressee. Once delivered, a resignation notice is irrevocable unless revocation is permitted by the Board of Directors.

ARTICLE III

COMMITTEES OF THE BOARD

3.1 COMMITTEES. The Board of Directors may create one or more committees and appoint members of the Board of Directors to serve on them. Each committee shall have two or more members. The creation of a committee and appointment of members to it must be approved by a majority of all directors in office when the action is taken.

Subject to any limitation imposed by the Board of Directors or by law, each committee may exercise all the authority of the Board of Directors in the management of the Corporation. A committee may not take any action that a committee is prohibited from taking by the Oregon Business Corporation Act.

3.2 CHANGES OF SIZE AND FUNCTION. Subject to the provisions of law, the Board of Directors shall have the power at any time to change the number of committee members, fill committee vacancies, change any committee members and change the functions and terminate the existence of a committee.

3.3 CONDUCT OF MEETINGS. Each committee shall conduct its meetings in accordance with the applicable provisions of these Bylaws relating to meetings and action without meetings of the Board of Directors. Each committee shall adopt any further rules regarding its conduct, keep minutes and other records and appoint subcommittees and assistants as it deems appropriate.

3.4 COMPENSATION. By resolution of the Board of Directors, committee members may be paid reasonable compensation for services on committees and their expenses of attending committee meetings.

ARTICLE IV

OFFICERS

4.1 APPOINTMENT. The Board of Directors at its first meeting following its election each year shall appoint a Chairman of the Board of Directors (“Chairman of the Board”), a President and a Secretary. The Board of Directors or the President may appoint any other officers, assistant officers and agents. Any two or more offices may be held by the same person.

7

 

 

7


 

4.2 COMPENSATION. The Corporation may pay its officers reasonable compensation for their services as fixed from time to time by the Board of Directors, or, with respect to officers appointed by the President, as fixed from time to time by the President.

4.3 TERM. The term of office of all officers commences upon their appointment and continues until their successors are appointed or until their resignation or removal.

4.4 REMOVAL. Any officer or agent appointed by the Board of Directors or the Chairman of the Board may be removed by the Board of Directors at any time with or without cause. Any officer or agent appointed by the Chairman of the Board may be removed by the Chairman of the Board at any time with or without cause.

4.5 CHAIRMAN OF THE BOARD. The Chairman of the Board shall preside at all meetings of the Board of Directors and shall perform any duties and responsibilities prescribed from time to time by the Board of Directors.

4.6 PRESIDENT. The President shall be the chief executive officer of the Corporation and, subject to the control of the Board of Directors , shall in general supervise and control all of the business and affairs of the Corporation. The President may execute in behalf of the Corporation all contracts, agreements, stock certificates and other instruments. The President shall from time to time report to the Board of Directors all matters within the President’s knowledge which should be brought to the attention of the Board of Directors. The President shall vote all shares of stock in other corporations owned by the Corporation, and shall be empowered to execute proxies, waivers of notice, consents and other instruments in the name of the Corporation with respect to such stock. The President shall have any other duties and responsibilities prescribed by the Board of Directors.

4.7 VICE PRESIDENTS. Each Vice President shall perform duties and responsibilities prescribed by the Board of Directors or the President. The Board of Directors or the President may confer a special title upon a Vice President.

4.8 SECRETARY.

(1) The Secretary shall record and keep the minutes of all meetings of the directors and shareholders in one or more books provided for that purpose and perform any duties prescribed by the Board of Directors or the President.

(2) Any assistant secretary shall have the duties prescribed from time to time by the Board of Directors, the President or the Secretary. In the absence or disability of the Secretary, the Secretary’s duties shall be performed by an assistant secretary.

4.9 CHIEF FINANCIAL OFFICER. The Chief Financial Officer shall have charge and custody and be responsible for all funds and securities of the Corporation and shall have other duties as prescribed from time to time by the Board of Directors or the President.

8

 

 

8


 

ARTICLE V

INDEMNIFICATION

The Corporation shall indemnify to the fullest extent not prohibited by law, any person who is made, or threatened to be made, a party to an action, suit or proceeding, whether civil, criminal, administrative, investigative or other (including an action, suit or proceeding by or in the right of the Corporation) by reason of the fact that such person is or was a director of the Corporation or a fiduciary within the meaning of the Employee Retirement Income Security Act of 1974 with respect to any employee benefit plan of the Corporation, or serves or served at the request of the Corporation as a director or as a fiduciary of an employee benefit plan, of another corporation, partnership, joint venture, trust or other enterprise. The Corporation shall pay for or reimburse the reasonable expenses incurred by any such person in any such proceeding to the fullest extent not prohibited by law. No amendment to these Bylaws that limits the Corporation’s obligation to indemnify any person shall have any effect on such obligation for any act or omission that occurs prior to the later to occur of the effective date of the amendment or the date notice of the amendment is given to the person. This Article shall not be deemed exclusive of any other provisions for indemnification or advancement of expenses of directors, officers, employees, agents and fiduciaries that may be included in the Articles of Incorporation or any statute, agreement, general or specific action of the Board of Directors, vote of shareholders or other document or arrangement.

ARTICLE VI

ISSUANCE OF SHARES

6.1 ADEQUACY OF CONSIDERATION. Before the Corporation issues shares, the Board of Directors shall determine that the consideration received or to be received for the shares to be issued is adequate. The authorization by the Board of Directors of the issuance of shares for stated consideration shall evidence a determination by the Board that such consideration is adequate.

6.2 CERTIFICATES FOR SHARES.

(1) Certificates representing shares of the Corporation shall be in any form determined by the Board of Directors consistent with the requirements of the Oregon Business Corporation Act and these Bylaws; provided that any shares of the Corporation may be uncertificated shares, whether upon original issuance, re-issuance or subsequent transfer. Shares represented by certificates shall be signed, either manually or in facsimile, by two officers of the Corporation, at least one whom shall be the Chairman of the Board, the President or a Vice President, and may be sealed with the seal of the Corporation, if any, or a facsimile thereof. All certificates for shares shall be consecutively numbered or otherwise identified. The signatures of officers upon a certificate may be facsimiles if the certificate is countersigned by a transfer agent or any assistant transfer agent or registered by a registrar, other than the Corporation itself or an employee of the Corporation. The name and address of the person to whom the shares represented thereby are issued, with the number of shares and date of issue, shall be entered on the stock transfer books of the Corporation. Except as otherwise provided by law, the rights and obligations of the holders of uncertificated shares and the rights and obligations of the holders of certificated shares shall be identical.

9

 

 

9


 

(2) Transfer of shares of the Corporation shall be made only on the stock transfer books of the Corporation by the holder of record thereof or by his legal representative, who shall furnish proper evidence of authority to transfer or by his attorney thereunto authorized by power of attorney duly executed and filed with the Secretary of the Corporation, or with its transfer agent, if any, and on surrender for cancellation of the certificate for such shares or upon proper instructions from the holder of uncertificated shares. The person in whose name shares stand on the books of the Corporation shall be deemed by the Corporation to be the owner thereof for all purposes.

(3) All certificates surrendered to the Corporation for transfer shall be canceled. The Corporation shall not issue a new certificate, or, upon request, evidence of the equivalent uncertificated shares, until the former certificate or certificates for a like number of shares shall have been surrendered and canceled, except that in case of a lost, destroyed or mutilated certificate a new one may be issued therefor upon terms prescribed by the Board of Directors. Upon receipt of proper transfer instructions from the holder of uncertificated shares, the Corporation shall cancel such uncertificated shares and issue new equivalent uncertificated shares, or, upon such holder’s request, certificated shares, to the person entitled thereto, and record the transaction upon its books.

6.3 TRANSFER AGENT AND REGISTRAR. The Board of Directors may from time to time appoint one or more transfer agents and one or more registrars for the shares of the Corporation, with powers and duties determined by the Board of Directors.

6.4 OFFICER CEASING TO ACT. If the person who signed a share certificate, either manually or in facsimile, no longer holds office when the certificate is issued, the certificate is nevertheless valid.

ARTICLE VII

CONTRACTS, LOANS, CHECKS AND OTHER INSTRUMENTS

7.1 CONTRACTS. Except as otherwise provided by law, the Board of Directors may authorize any officers or agents to execute and deliver any contract or other instrument in the name of and on behalf of the Corporation, and this authority may be general or confined to specific instances.

7.2 LOANS. The Corporation shall not borrow money and no evidence of indebtedness shall be issued in its name unless authorized by the Board of Directors. This authority may be general or confined to specific instances.

7.3 CHECKS, DRAFTS, ETC. All checks, drafts or other orders for the payment of money and notes or other evidences of indebtedness issued in the name of the Corporation shall be signed in the manner and by the officers or agents of the Corporation designated by the Board of Directors.

7.4 DEPOSITS. All funds of the Corporation not otherwise employed shall be deposited to the credit of the Corporation in those banks, trust companies or other depositaries as the Board of Directors or officers of the Corporation designated by the Board of Directors select, or be invested as authorized by the Board of Directors.

10

 

 

10


 

ARTICLE VIII

MISCELLANEOUS PROVISIONS

8.1 SEVERABILITY. A determination that any provision of these Bylaws is for any reason inapplicable, invalid, illegal or otherwise ineffective shall not affect or invalidate any other provision of these Bylaws.

8.2 AMENDMENTS. These Bylaws may be amended or repealed and new Bylaws may be adopted by the Board of Directors or the shareholders of the Corporation.

Amended March 21, 2007

11

 

 

11

EX-31.1 3 c70473exv31w1.htm EXHIBIT 31.1 exv31w1
 

EXHIBIT 31.1

CERTIFICATIONS

I, Scott C. Grout, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of RadiSys Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2007

/s/ SCOTT C. GROUT

Scott C. Grout
Chief Executive Officer and President

 

 

1

EX-31.2 4 c70473exv31w2.htm EXHIBIT 31.2 exv31w2
 

EXHIBIT 31.2

CERTIFICATIONS

I, Brian J. Bronson, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of RadiSys Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2007

/s/ BRIAN J. BRONSON

Brian J. Bronson
Chief Financial Officer

 

 

2

EX-32.1 5 c70473exv32w1.htm EXHIBIT 32.1 exv32w1
 

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of RadiSys Corporation (the “Company”) on Form 10-Q for the fiscal quarter ended March 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Scott C. Grout, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ SCOTT C. GROUT

Scott C. Grout
Chief Executive Officer
May 8, 2007

 

 

3

EX-32.2 6 c70473exv32w2.htm EXHIBIT 32.2 exv32w2
 

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of RadiSys Corporation (the “Company”) on Form 10-Q for the fiscal quarter ended March 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian J. Bronson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ BRIAN J. BRONSON

Brian J. Bronson
Chief Financial Officer
May 8, 2007

 

 

4

-----END PRIVACY-ENHANCED MESSAGE-----